{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:34:09Z","timestamp":1792524849089,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd006569.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,1,2]],"date-time":"2014-01-02T00:00:00Z","timestamp":1388620800000}}],"reference-count":381,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006569.pub5","type":"journal-article","created":{"date-parts":[[2014,1,2]],"date-time":"2014-01-02T16:47:18Z","timestamp":1388681238000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Aripiprazole versus other atypical antipsychotics for schizophrenia"],"prefix":"10.1002","volume":"2016","author":[{"given":"Priya","family":"Khanna","sequence":"first","affiliation":[{"name":"Northumberland, Tyne and Wear NHS Foundation Trust; Rehabilitation and Recovery, Adult Psychiatry; Newcastle UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Suo","sequence":"additional","affiliation":[{"name":"Zhongshan Hospital, Fudan University; Department of General Surgery, Institute of General Surgery; 180 Fenglin Road, Xuhui District Shanghai Shanghai China 200032"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Komossa","sequence":"additional","affiliation":[{"name":"University Hospital of Zurich; Department of Psychiatry and Psychotherapy; Culmannstrasse 8 Zurich Switzerland CH-8091"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaixing","family":"Ma","sequence":"additional","affiliation":[{"name":"Zhongshan Hospital, Fudan University; Department of Medical Oncology; Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Rummel-Kluge","sequence":"additional","affiliation":[{"name":"University of Leipzig; Clinic and Outpatient Clinic of Psychiatry and Psychotherapy; Semmelweisstrasse 10 Leipzig Saxony Germany 04103"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hany G","family":"El-Sayeh","sequence":"additional","affiliation":[{"name":"Tees, Esk & Wear Valleys NHS Foundation Trust; Harrogate District Hospital; Briary Wing Lancaster Park Road Harrogate North Yorkshire UK HG2 7SX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Leucht","sequence":"additional","affiliation":[{"name":"Technische Universit\u00e4t M\u00fcnchen Klinikum rechts der Isar; Klinik und Poliklinik f\u00fcr Psychiatrie und Psychotherapie; Ismaninger Stra\u00dfe 22 M\u00fcnchen Germany 81675"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xia","sequence":"additional","affiliation":[{"name":"The University of Nottingham; Cochrane Schizophrenia Group; Institute of Mental Health University of Nottingham Innovation Park, Triumph Road, Nottingham UK NG7 2TU"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,1,2]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD006569.pub5-BIB0001|cit1","first-page":"53","article-title":"Comparison study in the treatment of schizophrenia between aripiprazole and clozapine","volume":"18","author":"Ai","year":"2008","journal-title":"Linchuang Jingshen Yixue Zazhi [\u4e34\u5e8a\u7cbe\u795e\u533b\u5b66\u6742\u5fd7]"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub5-BIB0002|cit2","first-page":"39","article-title":"Comparative study on the efficacy of aripiprazole and clozapine in treatment of schizophrenia","volume":"1","author":"Bai","year":"2007","journal-title":"\u4e2d\u56fd\u4e34\u5e8a\u5b9e\u7528\u533b\u5b66"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0003|cit3","unstructured":"\u767d\u5251\u6587 ziprasidone and aripiprazole in the treatment of schizophrenia] Google Translate \u9752\u5c9b\u533b\u836f\u536b\u751f 2009 199 200"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub5-BIB0004|cit4","first-page":"292","article-title":"Analysis of the efficacy of aripiprazole and quetiapine in the treatment of schizophrenia","volume":"24","author":"Ban","year":"2008","journal-title":"Occupation and Health [\u804c\u4e1a\u4e0e\u5065\u5eb7]"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub5-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4088\/JCP.v68n0104","article-title":"Efficacy and safety of aripiprazole in the acute treatment of schizophrenia in Chinese patients with risperidone as an active control: A randomized trial","volume":"68","author":"Chan","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD006569.pub5-BIB0006|cit6","first-page":"S497","article-title":"Aripiprazole versus risperidone in the treatment of acutely relapsed patients with schizophrenia in Taiwan: a randomized controlled trial","volume":"14","author":"Hwang","year":"2005","journal-title":"Journal of the European College of Neuropsychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub5-BIB0007|cit7","first-page":"335","article-title":"A control study of aripiprazole vs. risperidone in the treatment of schizophrenia","volume":"13","author":"Chang","year":"2007","journal-title":"Journal of Clinical Psychosomatic Diseases [\u4e34\u5e8a\u5fc3\u8eab\u75be\u75c5\u6742\u5fd7]"},{"issue":"9","key":"10.1002\/14651858.CD006569.pub5-BIB0008|cit8","first-page":"404","article-title":"Comparative study of therapeutic effects between aripiprazole and risperidone on schizophrenia","volume":"27","author":"Chen","year":"2006","journal-title":"Shanghai Medical and Pharmaceutical Journal [\u4e0a\u6d77\u533b\u836f]"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0009|cit9","unstructured":"\u9648\u98de \u738b\u7ea2\u8273 \u674e\u5fb7\u548f \u5468\u4fdd\u536b \u7a0b\u592b\u82f1 Aripiprazole, quetiapine treatment of female episode schizophrenia Shandong Archives of Psychiatry [\u5c71\u4e1c\u7cbe\u795e\u533b\u5b66] 2007 381 3"},{"issue":"35","key":"10.1002\/14651858.CD006569.pub5-BIB0010|cit10","first-page":"5454","article-title":"Aripiprazole and risperidone in the treatment of female schizophrenia","volume":"17","author":"\u9648\u9707\u96f7","year":"2008","journal-title":"Modern Research of Integrated Chinese and Western Medicine [\u73b0\u4ee3\u4e2d\u897f\u533b\u7ed3\u5408\u6742\u5fd7]"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub5-BIB0011|cit11","first-page":"53","article-title":"Aripiprazole and quetiapine in the treatment of schizophrenia] Google Translate","volume":"22","author":"\u9648\u7ea2\u82f1","year":"2009","journal-title":"Shandong Archives of Psychiatry [\u5c71\u4e1c\u7cbe\u795e\u533b\u5b66]"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub5-BIB0012|cit12","first-page":"261","article-title":"Comparative study between aripiprazole and olanzapine in the treatment of agitated schizophrenia","volume":"19","author":"\u9648\u8fdc\u5cad","year":"2009","journal-title":"Linchuang Jingshen Yixue Zazhi [\u4e34\u5e8a\u7cbe\u795e\u533b\u5b66\u6742\u5fd7]"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0013|cit13","unstructured":"\u9648\u5e73\u52cb \u7f57\u5efa\u6148 \u5218\u6843\u82b3 Aripiprazole and risperidone in the treatment of schizophrenia in the clinical control study] Google Translate Medical Journal of Chinese People's Health [\u4e2d\u56fd\u6c11\u5eb7\u533b\u5b66] 2010 2249 50"},{"issue":"17","key":"10.1002\/14651858.CD006569.pub5-BIB0014|cit14","first-page":"2180","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia starting] Google Translate","volume":"22","author":"\u9648\u6069\u6c11","year":"2010","journal-title":"Medical Journal of Chinese People's Health [\u4e2d\u56fd\u6c11\u5eb7\u533b\u5b66]"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub5-BIB0015|cit15","first-page":"106","article-title":"Ziprasidone and Aripiprazole in the treatment of schizophrenia with predominantly negative symptoms","volume":"23","author":"\u7a0b\u5e73","year":"2009","journal-title":"Journal of the Xianning Medical College [\u65b0\u4e61\u533b\u5b66\u9662\u5b66\u62a5]"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub5-BIB0016|cit16","first-page":"20","article-title":"Compare the aripiprazole with risperidone to treat schizophrenia disease","volume":"29","author":"CuiMeng","year":"2008","journal-title":"Journal of the Mudanjiang Medical College"},{"issue":"8","key":"10.1002\/14651858.CD006569.pub5-BIB0017|cit17","first-page":"712","article-title":"Comparison of efficacy and safety of aripiprazole and quetiapine in the treatment of schizophrenia","volume":"14","author":"Dai","year":"2005","journal-title":"Chinese Journal of Behavioral Medical Science [\u4e2d\u56fd\u884c\u4e3a\u533b\u5b66\u79d1\u5b66]"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub5-BIB0018|cit18","first-page":"14","article-title":"A comparison of schizophrenia with aripiprazole and risperidone","volume":"26","author":"Dai","year":"2006","journal-title":"Journal of the Datong Medical College"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub5-BIB0019|cit19","first-page":"28","article-title":"Effects were compared aripiprazole in the treatment of elderly schizophrenia","volume":"21","author":"\u9093\u514b\u6587","year":"2008","journal-title":"Sichuan Mental Health [\u56db\u5ddd\u7cbe\u795e\u536b\u751f]"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0020|cit20","first-page":"755","article-title":"Control study of domestic aripiprazole and risperidone in the treatment of schizophrenia","volume":"5","author":"\u9093\u534e","year":"2008","journal-title":"Journal of the Youjiang Medical College for Nationalities"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0021|cit21","unstructured":"\u4e01\u6c38\u7ea2 \u5468\u5e86\u6d77 \u9093\u91d1\u82f1 Aripiprazole and risperidone in the treatment of schizophrenia \u4e2d\u56fd\u73b0\u4ee3\u533b\u751f 2007 87"},{"issue":"13","key":"10.1002\/14651858.CD006569.pub5-BIB0022|cit22","first-page":"1065","article-title":"Study on effects of aripiprazole on serum prolactin level and body weight","volume":"9","author":"Du","year":"2006","journal-title":"Chinese General Practice [\u4e2d\u56fd\u5168\u79d1\u533b\u5b66]"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub5-BIB0023|cit23","first-page":"377","article-title":"Efficacy analysis of aripiprazole and clozapine in the treatment of schizophrenia","volume":"20","author":"Fan","year":"2005","journal-title":"Journal of North Sichuan Medical College"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0024|cit24","unstructured":"\u8303\u6587\u6f9c \u4f59\u6210\u6c11 \u674e\u6b63\u53d1 Aripiprazole and risperidone in the treatment of schizophrenia] Google Translate \u897f\u90e8\u533b\u5b66 2010 1051 2"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub5-BIB0025|cit25","first-page":"418","article-title":"The clinical study on aripiprazole and risperidone in trea tment of first-onset schizophrenia","volume":"14","author":"Feng","year":"2006","journal-title":"Chinese Journal of Health Psychology [\u4e2d\u56fd\u5065\u5eb7\u5fc3\u7406\u5b66\u6742\u5fd7]"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0026|cit26","unstructured":"BMS A multicenter, double-blind, randomized, comparative study of aripiprazole and olanzapine in the treatment of patients with acute schizophrenia Clinical Study Report CN138003 2005"},{"issue":"8","key":"10.1002\/14651858.CD006569.pub5-BIB0027|cit27","first-page":"905","article-title":"Comparative study of Aripiprazole with risperidone in the treatment of adolescent patients with first episode schizophrenia","volume":"30","author":"\u5085\u6df1\u7701","year":"2009","journal-title":"Journal of Qiqihar Medical College [\u9f50\u9f50\u54c8\u5c14\u533b\u5b66\u9662\u5b66\u62a5]"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0028|cit28","unstructured":"\u8881\u7eaf\u73b2 Quetiapine and aripiprazole in the treatment control study of first-episode schizophrenia] Google Translate \u4e2d\u56fd\u73b0\u4ee3\u836f\u7269\u5e94\u7528 2009 71"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub5-BIB0029|cit29","first-page":"46","article-title":"Aripiprazole and quetiapine in the treatment of women with schizophrenia] Google Translate","volume":"13","author":"\u845b\u6dd1\u541b","year":"2010","journal-title":"Chinese General Practice [\u4e2d\u56fd\u5168\u79d1\u533b\u5b66]"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub5-BIB0030|cit30","first-page":"716","article-title":"A randomized and double-blind controlled clinical trial of aripiprazole in the treatment of schizophrenia","volume":"23","author":"Guo","year":"2006","journal-title":"Journal of Clinical Research"},{"issue":"12","key":"10.1002\/14651858.CD006569.pub5-BIB0031|cit31","first-page":"995","article-title":"Quality of life in schizophrenics treated with aripiprazole or clozapine","volume":"12","author":"Han","year":"2006","journal-title":"Chinese Journal of Rehabilitation Theory and Practice"},{"issue":"10","key":"10.1002\/14651858.CD006569.pub5-BIB0032|cit32","first-page":"853","article-title":"A controlled study of schizophrenia treated with aripiprazole and clozapine","volume":"11","author":"Han","year":"2005","journal-title":"Chinese Journal of Rehabilitation Theory and Practice [\u4e2d\u56fd\u5eb7\u590d\u7406\u8bba\u4e0e\u5b9e\u8df5]"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub5-BIB0033|cit33","first-page":"28","article-title":"Clinical effect of the domestic olanzapine and aripiprazole in the treatment of schizophrenia","volume":"15","author":"Han","year":"2007","journal-title":"Chinese Journal of Health Psychology [\u4e2d\u56fd\u5065\u5eb7\u5fc3\u7406\u5b66\u6742\u5fd7]"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0034|cit34","unstructured":"\u97e9\u96ea\u5cf0 \u8303\u8fde\u6885 Aripiprazole and risperidone in the treatment of clinical studies of schizophrenia Journal of Practical Medical Techniques [\u5b9e\u7528\u533b\u6280\u6742\u5fd7] 2007 4298 9"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub5-BIB0035|cit35","first-page":"41","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia] Google Translate","volume":"22","author":"\u80e1\u4e9a\u6e58","year":"2010","journal-title":"Tianjin Pharmacy"},{"issue":"16","key":"10.1002\/14651858.CD006569.pub5-BIB0036|cit36","first-page":"15","article-title":"A comparative study in earlier schizophrenic patients treated with aripiprazole and risperidone","volume":"7","author":"\u9ec4\u6cb3\u4eae","year":"2009","journal-title":"\u4e2d\u56fd\u533b\u836f\u6307\u5357"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub5-BIB0037|cit37","first-page":"261","article-title":"A study of aripiprazole and risperidone in treatment of schizophrenia","volume":"17","author":"Ji","year":"2007","journal-title":"Linchuang Jingshen Yixue Zazhi [\u4e34\u5e8a\u7cbe\u795e\u533b\u5b66\u6742\u5fd7]"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub5-BIB0038|cit38","first-page":"87","article-title":"Aripiprazole and clozapine in treatment refractory schizophrenia randomized controlled study] Google Translate","volume":"38","author":"Jiang","year":"2009","journal-title":"Chongqing Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub5-BIB0039|cit39","first-page":"107","article-title":"Aripiprazole and clozapine treatment of schizophrenia with predominantly negative symptoms","volume":"21","author":"Jie","year":"2008","journal-title":"Sichuan Mental Health"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub5-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1185\/03007995.2010.537594","article-title":"Cost-effectiveness of olanzapine vs. aripiprazole in the treatment of schizophrenia","volume":"27","author":"Ascher-Svanum","year":"2011","journal-title":"Current Medical Research and Opinion"},{"issue":"7 Suppl","key":"10.1002\/14651858.CD006569.pub5-BIB0041|cit41","first-page":"289S","article-title":"A 28-week, randomized, double-blind study of olanzapine versus aripiprazole in the treatment of schizophrenia","volume":"63","author":"Kane","year":"2008","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0042|cit42","doi-asserted-by":"crossref","unstructured":"Kane JM Osuntokun O Kryzhanovskaya LA Xu W Stauffer V Watson SB A 28-week, randomized, double-blind study of olanzapine versus aripiprazole in the treatment of schizophrenia Proceedings of the 63rd Annual Convention of the Society of Biological Psychiatry 2008","DOI":"10.1016\/S0920-9964(08)70798-9"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub5-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"572","DOI":"10.4088\/JCP.08m04421","article-title":"A 28-week, randomized, double-blind study of olanzapine versus aripiprazole in the treatment of schizophrenia","volume":"70","author":"Kane","year":"2009","journal-title":"Journal of Clinical Psychiatry"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006569.pub5-BIB0044|cit44","first-page":"153","article-title":"A 28-week, randomized, double-blind study of olanzapine versus aripiprazole in the treatment of schizophrenia","volume":"11","author":"Osuntokun","year":"2008","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0045|cit45","unstructured":"Watson SB Kane JM Osuntokun O Kryzhanovskaya LA Xu W Stauffer V A 28-week, randomized, double-blind study of olanzapine versus aripiprazole in the treatment of schizophrenia Proceedings of the 161st Annual Meeting of the American Psychiatric Association; 2008 May 3-8; Washington DC, USA 2008"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub5-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s00213-006-0428-x","article-title":"The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine","volume":"187","author":"Kern","year":"2006","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub5-BIB0047|cit47","first-page":"421","article-title":"Changes in prolactin levels and arizona sexual experience scale (ASEX) scores among patients switched from risperidone to aripiprazole in the schizophrenia trial of aripiprazole (STAR) study","volume":"33","author":"Beuzen","year":"2007","journal-title":"Schizophrenia Bulletin"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub5-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"741","DOI":"10.4088\/JCP.v69n0507","article-title":"Predicted risk of diabetes and coronary heart disease in patients with schizophrenia: aripiprazole versus standard of care","volume":"69","author":"Blonde","year":"2008","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub5-BIB0050|cit49","first-page":"432","article-title":"Reasons for switching from previous therapy and preference of medication in the large, randomized, naturalistic schizophrenia trial of aripiprazole (STAR)","volume":"33","author":"Hanssens","year":"2007","journal-title":"Schizophrenia Bulletin"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006569.pub5-BIB0049|cit50","first-page":"S99","article-title":"Evaluation of quality of life in community-treated schizophrenic patients: a naturalistic, open-label study comparing aripiprazole to standard-of-care (Schizophrenia Trial of aripiprazole: STAR study)","volume":"21","author":"Hanssens","year":"2006","journal-title":"European Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD006569.pub5-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.eurpsy.2007.03.002","article-title":"A multi centre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of aripiprazole: (STAR) study","volume":"22","author":"Kerwin","year":"2007","journal-title":"European Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub5-BIB0052|cit52","first-page":"105","article-title":"A multi centre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients. Schizophrenic Trial of aripiprazole: (STAR) study","volume":"11","author":"Kerwin","year":"2008","journal-title":"Wiadomosci Psychiatryczne"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub5-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1185\/03007995.2010.542745","article-title":"Cost-effectiveness analysis of aripiprazole vs standard-of-care in the management of community-treated patients with schizophrenia: Star study","volume":"27","author":"King","year":"2011","journal-title":"Current Medical Research and Opinion"},{"issue":"8","key":"10.1002\/14651858.CD006569.pub5-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.eurpsy.2008.01.1421","article-title":"Changes in weight and weight-related quality of life in a multi centre, randomized trial of aripiprazole versus standard of care","volume":"23","author":"Kolotkin","year":"2008","journal-title":"European Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub5-BIB0055|cit55","first-page":"439","article-title":"Metabolic effects of aripiprazole versus olanzapine, quetiapine, or risperidone (the STAR trial)","volume":"33","author":"L'Italien","year":"2007","journal-title":"Schizophrenia Bulletin"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006569.pub5-BIB0056|cit56","first-page":"A538","article-title":"Prevalence of diabetes\/cardiovascular risk factors among schizophrenia patients treated with atypical antipsychotics in a multicenter, randomized, naturalistic, open-label study (Schizophrenia Trial of aripiprazole: STAR study)","volume":"55","author":"L'Italien","year":"2006","journal-title":"Diabetes"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0057|cit57","unstructured":"L'ltalien GJ Hanssens L Marcus RN McQuade RD Evidence of antipsychotic treatment selection based on metabolic risk factors among community-based schizophrenia patients (The STAR Trial) Proceedings of the 160th Annual Meeting of the American Psychiatric Association; 2007 May 19-24; San Diego, CA 2007"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0058|cit58","unstructured":"Millet B A multicenter, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients (Schizophrenia Trial of aripiprazole - STAR) http:\/\/www.clinicaltrials.gov 2005"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub5-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.eurpsy.2008.03.006","article-title":"Preference of medicine and patient-reported quality of life in community-treated schizophrenic patients receiving aripiprazole vs standard of care: results from the STAR study","volume":"23","author":"Taylor","year":"2008","journal-title":"European Psychiatry"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0060|cit60","unstructured":"Eli Lilly Company Olanzapine versus aripiprazole in the treatment of acutely ill patients with schizophrenia Eli Lilly and Company Clinical Trial Registry 2004"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub5-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/JCP.0b013e31818aaf6c","article-title":"Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia","volume":"28","author":"Kinon","year":"2008","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0062|cit62","doi-asserted-by":"crossref","unstructured":"Stauffer V Kinon B Kollack-Walker S Chen L Sniadecki J Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia Proceedings of the 161st Annual Meeting of the American Psychiatric Association; 2008 May 3-8; Washington DC, USA 2008","DOI":"10.1016\/S0920-9964(08)70774-6"},{"issue":"9","key":"10.1002\/14651858.CD006569.pub5-BIB0064|cit63","first-page":"690","article-title":"A controlled study on quality of life of schizophrenia treated with aripiprazole and clozapine","volume":"18","author":"Kuang","year":"2006","journal-title":"Medical Journal of Chinese Civil Administration[\u4e2d\u56fd\u6c11\u5eb7\u533b\u5b66]"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub5-BIB0063|cit64","first-page":"426","article-title":"A controlled study on compliance of schizophrenia treated with aripirazole and clozapine","volume":"14","author":"Kuang","year":"2006","journal-title":"Chinese Journal of Clinical Psychology[\u4e2d\u56fd\u4e34\u5e8a\u5fc3\u7406\u5b66\u6742\u5fd7]"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub5-BIB0065|cit65","first-page":"196","article-title":"A comparative study of aripiprazole and risperidone in the treatment of first-episode schizophrenia","volume":"19","author":"Li","year":"2006","journal-title":"Shandong Archives of Psychiatry [\u5c71\u4e1c\u7cbe\u795e\u533b\u5b66]"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0066|cit66","unstructured":"Li L-X Lian H-T A comparative study of aripiprazole and risperidone in the treatment of schizophrenia Medical Journal of Chinese People's Health [\u4e2d\u56fd\u6c11\u5eb7\u533b\u5b66] 2006 723 4"},{"issue":"10","key":"10.1002\/14651858.CD006569.pub5-BIB0067|cit67","first-page":"956","article-title":"Comparative study of influence of aripiprazole on life quality in schizophrenic patients","volume":"15","author":"Li","year":"2007","journal-title":"Chinese Journal of Health Psychology"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub5-BIB0069|cit68","first-page":"404-6.[MEDLINE:","article-title":"Effects of aripiprazole and clozapine on life quality of schizophrenics","volume":"13","author":"Li","year":"2007","journal-title":"Journal of Clinical Psychosomatic Diseases"},{"issue":"15","key":"10.1002\/14651858.CD006569.pub5-BIB0068|cit69","first-page":"1939","article-title":"Aripiprazole and clozapine on quality of life of patients with schizophrenia] Google Translate","volume":"22","author":"\u9648\u73b2","year":"2010","journal-title":"Medical Journal of Chinese People's Health [\u4e2d\u56fd\u6c11\u5eb7\u533b\u5b66]"},{"issue":"11A","key":"10.1002\/14651858.CD006569.pub5-BIB0070|cit70","first-page":"49","article-title":"Aripiprazole and quetiapine in the treatment of schizophrenia","volume":"30","author":"\u674e\u7f8e\u82b1","year":"2007","journal-title":"\u4e2d\u56fd\u533b\u5e08\u8fdb\u4fee\u6742\u5fd7"},{"issue":"11","key":"10.1002\/14651858.CD006569.pub5-BIB0071|cit71","first-page":"77","article-title":"Comparison of efficacy and safety of aripiprazole and ziprasidone in the treatment of schizophrenia","volume":"13","author":"Li","year":"2007","journal-title":"International Medicine and Health Guidance News [\u56fd\u9645\u533b\u836f\u536b\u751f\u5bfc\u62a5]"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub5-BIB0072|cit72","first-page":"100","article-title":"Control studies of domestic aripiprazole vs. risperidone in the treatment of schizophrenia","volume":"13","author":"Li","year":"2007","journal-title":"Journal of Clinical Psychosomatic Diseases [\u4e34\u5e8a\u5fc3\u8eab\u75be\u75c5\u6742\u5fd7]"},{"issue":"16","key":"10.1002\/14651858.CD006569.pub5-BIB0073|cit73","first-page":"135","article-title":"Aripiprazole and clozapine treatment of schizophrenia control study of efficacy and safety] Google Translate","volume":"25","author":"\u674e\u6653\u82f1","year":"2009","journal-title":"\u7518\u8083\u79d1\u6280"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0074|cit74","unstructured":"\u674e\u4ee3\u79c0 \u9648\u6ce2 \u4e01\u9759\u534e Aripiprazole and risperidone in the treatment of schizophrenia compared] Google Translate Baotou Medical Journal 2009 13 4"},{"issue":"18","key":"10.1002\/14651858.CD006569.pub5-BIB0075|cit75","first-page":"166","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia] Google Translate","volume":"4","author":"\u674e\u6653\u534e","year":"2009","journal-title":"\u4e2d\u56fd\u5b9e\u7528\u533b\u836f"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0076|cit76","unstructured":"\u8fde\u6811\u594e \u6797\u5fb7\u9896 Aripiprazole and risperidone in the treatment of schizophrenia \u4e2d\u56fd\u73b0\u4ee3\u533b\u751f 2008 91 2"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0077|cit77","unstructured":"\u6881\u4f73 \u9676\u5efa\u9752 \u5eb7\u7ea2 Compliance control study of aripiprazole and risperidone in the treatment of patients with schizophrenia Guangxi Medical Journal 2008 30 1"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0078|cit78","unstructured":"Liu S Ren C Song X Comparative study between aripiprazole and clozapine in the treatment of first-episode schizophrenia Chinese Journal of Health Psychology [\u4e2d\u56fd\u5065\u5eb7\u5fc3\u7406\u5b66\u6742\u5fd7] 2006 658 9"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub5-BIB0079|cit79","first-page":"420","article-title":"A control study on aripiprazole and risperidone in the treatment of schizophrenia","volume":"14","author":"Liu","year":"2006","journal-title":"Chinese Journal of Health Psychology [\u4e2d\u56fd\u5065\u5eb7\u5fc3\u7406\u5b66\u6742\u5fd7]"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub5-BIB0080|cit80","first-page":"500-1, 507","article-title":"A control study on aripiprazole vs. clozapine in the treatment of refractory schizophrenia","volume":"13","author":"Liu","year":"2007","journal-title":"Journal of Clinical Psychosomatic Diseases [\u4e34\u5e8a\u5fc3\u8eab\u75be\u75c5\u6742\u5fd7]"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0081|cit81","unstructured":"Liu J Ren J Wang Y Aripiprazole and clozapine treatment episode schizophrenia \u4e2d\u56fd\u5b9e\u7528\u533b\u836f 2008 55 7"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0082|cit82","unstructured":"Liu W Zhang X A comparative study of ziprasidone and aripiprazole in the treatment of schizophrenia with predominantly negative symptoms Chinese Journal of Health Psychology [\u4e2d\u56fd\u5065\u5eb7\u5fc3\u7406\u5b66\u6742\u5fd7] 2008 124 5"},{"issue":"19","key":"10.1002\/14651858.CD006569.pub5-BIB0083|cit83","first-page":"110","article-title":"Aripiprazole for schizophrenia patients with psychiatric symptoms and quality of life impact","volume":"5","author":"\u5218\u4ece\u654f","year":"2008","journal-title":"\u4e2d\u56fd\u533b\u836f\u5bfc\u62a5"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0084|cit84","unstructured":"\u5218\u4f1f\u950b \u5f20\u536b\u654f Aripiprazole and risperidone in the treatment of refractory schizophrenia Efficacy Medical Journal of Chinese People's Health [\u4e2d\u56fd\u6c11\u5eb7\u533b\u5b66] 2008 224 5"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub5-BIB0085|cit85","first-page":"276","article-title":"Aripiprazole and risperidone in the treatment episode schizophrenia","volume":"25","author":"\u5218\u5ce5\u5d58","year":"2008","journal-title":"Chinese Medical Journal of Metallurgical Industry [\u4e2d\u56fd\u51b6\u91d1\u5de5\u4e1a\u533b\u5b66\u6742\u5fd7]"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0086|cit86","unstructured":"\u5218\u5a1f \u674e\u6d2a\u82f1 Aripiprazole and olanzapine schizophrenia] Google Translate Shandong Archives of Psychiatry [\u5c71\u4e1c\u7cbe\u795e\u533b\u5b66] 2009 339 40"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0087|cit87","unstructured":"\u5218\u5fd7\u4e1c Aripiprazole and risperidone in the treatment of schizophrenia Journal of Medical Theory and Practice 2009 1072 3"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub5-BIB0088|cit88","first-page":"42","article-title":"Aripiprazole and quetiapine in the treatment of schizophrenia] Google Translate","volume":"22","author":"\u5218\u660a","year":"2009","journal-title":"Shandong Archives of Psychiatry [\u5c71\u4e1c\u7cbe\u795e\u533b\u5b66]"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub5-BIB0089|cit89","first-page":"646","article-title":"Clozapine, risperidone and aripiprazole adverse drug reactions cost - effectiveness analysis] Google Translate","volume":"18","author":"\u5218\u5349\u5170","year":"2010","journal-title":"Chinese Journal of Health Psychology [\u4e2d\u56fd\u5065\u5eb7\u5fc3\u7406\u5b66\u6742\u5fd7]"},{"issue":"12","key":"10.1002\/14651858.CD006569.pub5-BIB0090|cit90","first-page":"1064, 1067","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia","volume":"19","author":"\u674e\u66e6","year":"2007","journal-title":"Medical Journal of Chinese People's Health [\u4e2d\u56fd\u6c11\u5eb7\u533b\u5b66]"},{"issue":"20","key":"10.1002\/14651858.CD006569.pub5-BIB0091|cit91","first-page":"1709","article-title":"Effect of aripiprazole on late-onset schizophrenia and cognitive function","volume":"16","author":"Lou","year":"2007","journal-title":"Chinese New Drugs Journal [\u4e2d\u56fd\u65b0\u836f\u6742\u5fd7]"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub5-BIB0092|cit92","first-page":"191","article-title":"Comparison of quetiapine and aripiprazole in the treatment of first episode schizophrenia","volume":"18","author":"Luo","year":"2008","journal-title":"Linchuang Jingshen Yixue Zazhi [\u4e34\u5e8a\u7cbe\u795e\u533b\u5b66\u6742\u5fd7]"},{"issue":"170","key":"10.1002\/14651858.CD006569.pub5-BIB0093|cit93","first-page":"101","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia efficacy analysis","volume":"15","author":"\u7f57\u6765\u5174","year":"2009","journal-title":"\u5f53\u4ee3\u533b\u5b66"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub5-BIB0094|cit94","first-page":"181","article-title":"A comparative study on aripiprazole and risperidone in the treatment of schizophrenic patients","volume":"19","author":"Lv","year":"2007","journal-title":"Medical Journal of Chinese People's Health [\u4e2d\u56fd\u6c11\u5eb7\u533b\u5b66]"},{"issue":"23","key":"10.1002\/14651858.CD006569.pub5-BIB0095|cit95","first-page":"59","article-title":"Aripiprazole and olanzapine in negative symptoms in schizophrenia] Google Translate","volume":"18","author":"\u9ebb\u663e\u5a07","year":"2009","journal-title":"China Pharmaceuticals [\u4e2d\u570b\u85e5\u696d]"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub5-BIB0096|cit96","first-page":"643","article-title":"Efficacy of aripiprazole and risperidone in the treatment of early schizophrenia","volume":"17","author":"\u9a6c\u5fe0\u667a","year":"2009","journal-title":"Chinese Journal of Health Psychology [\u4e2d\u56fd\u5065\u5eb7\u5fc3\u7406\u5b66\u6742\u5fd7]"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub5-BIB0097|cit97","first-page":"184","article-title":"Comparative study on the effect of aripiprazole and risperidone on schizophrenia","volume":"20","author":"Mai","year":"2005","journal-title":"Chinese Journal of Rehabilitation [\u4e2d\u570b\u5eb7\u5fa9]"},{"issue":"11","key":"10.1002\/14651858.CD006569.pub5-BIB0098|cit98","first-page":"1365","article-title":"Olanzapine and aripiprazole in the treatment of refractory schizophrenia control study of 70 cases] Google Translate","volume":"22","author":"\u6bdb\u661f","year":"2010","journal-title":"Medical Journal of Chinese People's Health [\u4e2d\u56fd\u6c11\u5eb7\u533b\u5b66]"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0099|cit99","unstructured":"Abou Gharbia N McQuade R Jody D Kujawa M Carson W Iwamoto T Comparative study of the long-term effects of aripiprazole and olanzapine treatment on body weight Proceedings of the Thematic Conference of the World Psychiatric Association on \"Treatments in Psychiatry: An Update\"; 2004 Nov 10-13; Florence, Italy 2004"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD006569.pub5-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"S275","DOI":"10.1016\/S0924-977X(04)80317-1","article-title":"The risk of new-onset type 2 diabetes and coronary heart disease in chronic schizophrenic patients treated with aripiprazole and olanzapine","volume":"14","author":"Blonde","year":"2004","journal-title":"Journal of the European College of Neuropsychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub5-BIB0101|cit101","first-page":"187","article-title":"Long-term weight effects of aripiprazole versus olanzapine","volume":"67","author":"Jody","year":"2004","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0102|cit102","unstructured":"McQuade RD Jody D Kujawa MJ Carson WH Iwamoto T Archibald DG Long-term weight effects of aripiprazole versus olanzapine Proceedings of the 156th Annual Meeting of the American Psychiatric Association; 2003 May 17-22; San Francisco, California, USA 2003"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub5-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0920-9964(03)80498-X","article-title":"Aripiprazole for long-term maintenance treatment of schizophrenia","volume":"60","author":"McQuade","year":"2003","journal-title":"Schizophrenia Research"},{"issue":"Suppl 18","key":"10.1002\/14651858.CD006569.pub5-BIB0104|cit104","first-page":"47","article-title":"A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study","volume":"65","author":"McQuade","year":"2004","journal-title":"Journal of Clinical Psychiatry"},{"issue":"Suppl 18","key":"10.1002\/14651858.CD006569.pub5-BIB0105|cit105","first-page":"47","article-title":"A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study","volume":"65","author":"McQuade","year":"2004","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub5-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4088\/JCP.08m04267","article-title":"The moderating impact of ethnicity on metabolic outcomes during treatment with olanzapine and aripiprazole in patients with schizophrenia","volume":"70","author":"Meyer","year":"2009","journal-title":"Journal of Clinical Psychiatry"},{"issue":"23","key":"10.1002\/14651858.CD006569.pub5-BIB0107|cit107","first-page":"2781, 2783","article-title":"Domestic aripiprazole and risperidone in the treatment of female schizophrenia","volume":"20","author":"\u7a46\u5fb7\u519b","year":"2008","journal-title":"Medical Journal of Chinese People's Health [\u4e2d\u56fd\u6c11\u5eb7\u533b\u5b66]"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0108|cit108","first-page":"641","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia compared] Google Translate","volume":"3","author":"\u6c90\u5fd7\u5f3a","year":"2010","journal-title":"Medical Information"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub5-BIB0109|cit109","first-page":"363","article-title":"A controlled study of aripiprazole and risperdal in the treatment of schizophrenia","volume":"15","author":"Pan","year":"2007","journal-title":"Chinese Journal of Health Psychology [\u4e2d\u56fd\u5065\u5eb7\u5fc3\u7406\u5b66\u6742\u5fd7]"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub5-BIB0110|cit110","first-page":"329","article-title":"A clinical analysis of aripiprazole and quetiapine in treatment of first episode schizophrenia","volume":"17","author":"Peng","year":"2007","journal-title":"Linchuang Jingshen Yixue Zazhi [\u4e34\u5e8a\u7cbe\u795e\u533b\u5b66\u6742\u5fd7]"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub5-BIB0111|cit111","first-page":"237","article-title":"Comparative study between aripiprazole and clozapine in the treatment of schizophrenia","volume":"27","author":"Peng","year":"2007","journal-title":"Journal of the Gannan Medical College [\u8d63\u5357\u533b\u5b66\u9662\u5b66\u62a5]"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0920-9964(03)80511-X","article-title":"Aripiprazole and risperidone versus placebo in schizophrenia and schizoaffective disorder","volume":"60","author":"Potkin","year":"2003","journal-title":"Schizophrenia Research"},{"issue":"7","key":"10.1002\/14651858.CD006569.pub5-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/archpsyc.60.7.681","article-title":"Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder","volume":"60","author":"Potkin","year":"2003","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0114|cit114","unstructured":"Pu S-B Liang J-X Zhang W-S The comparison of blood prolactin and body index in the female patients with psychosis treated by aripiprazole and risperidone Medical Journal of Chinese People's Health [\u4e2d\u56fd\u6c11\u5eb7\u533b\u5b66] 2007 163-4, 7"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0115|cit115","unstructured":"\u94b1\u6587\u80dc Aripiprazole and olanzapine treatment of female control study of patients with schizophrenia] Google Translate \u5175\u56e2\u533b\u5b66 2009 28 9"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub5-BIB0116|cit116","first-page":"284, 300","article-title":"Aripiprazole and risperidone in the treatment of chronic schizophrenia","volume":"20","author":"\u79e6\u7231\u73b2","year":"2008","journal-title":"Medical Journal of Chinese People's Health [\u4e2d\u56fd\u6c11\u5eb7\u533b\u5b66]"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0117|cit117","unstructured":"\u66f2\u4e07\u4ec1 The comparison for effect of treating schizophrenia with aripiprazole and risperidone Chinese Journal of Ethnomedicine and Ethnopharmacy 2009 33"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub5-BIB0118|cit118","first-page":"119-20, 133","article-title":"A controlled study of aripiprazole vs. risperidone in the treatment of schizophrenia","volume":"14","author":"Shan","year":"2008","journal-title":"Journal of Clinical Psychosomatic Diseases [\u4e34\u5e8a\u5fc3\u8eab\u75be\u75c5\u6742\u5fd7]"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub5-BIB0119|cit119","first-page":"35","article-title":"Evaluating the effect and safety of aripirazole and risperidone","volume":"10","author":"Shuai","year":"2008","journal-title":"\u4e2d\u56fd\u73b0\u4ee3\u533b\u836f\u6742\u5fd7"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0120|cit120","unstructured":"\u5b8b\u8273\u840d Comparative analysis of aripiprazole and risperidone in the treatment of female schizophrenia Sichuan Mental Health [\u56db\u5ddd\u7cbe\u795e\u536b\u751f] 2008 34 5"},{"issue":"19","key":"10.1002\/14651858.CD006569.pub5-BIB0121|cit121","first-page":"67","article-title":"Aripiprazole Comparative Study of Risperidone in the treatment of schizophrenia] Google Translate","volume":"30","author":"\u5b8b\u957f\u60e0","year":"2009","journal-title":"Journal of Medical Forum [\u533b\u836f\u8bba\u575b\u6742\u5fd7]"},{"issue":"8","key":"10.1002\/14651858.CD006569.pub5-BIB0122|cit122","first-page":"970, 986","article-title":"Olanzapine and aripiprazole in the treatment of schizophrenia] Google Translate","volume":"22","author":"\u5b8b\u82b3","year":"2010","journal-title":"Medical Journal of Chinese People's Health [\u4e2d\u56fd\u6c11\u5eb7\u533b\u5b66]"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0123|cit123","unstructured":"\u6817\u5c0f\u7ea2 Aripiprazole and risperidone in the treatment of schizophrenia Shandong Archives of Psychiatry [\u5c71\u4e1c\u7cbe\u795e\u533b\u5b66] 2007 313 4"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub5-BIB0124|cit124","first-page":"409","article-title":"A comparative study of olanzapine and aripiprazole in treatment of schizophrenia","volume":"18","author":"Su","year":"2008","journal-title":"Linchuang Jingshen Yixue Zazhi [\u4e34\u5e8a\u7cbe\u795e\u533b\u5b66\u6742\u5fd7]"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub5-BIB0125|cit125","first-page":"424","article-title":"Effect of aripiprazole on coginiton function in patients with schizophrenic","volume":"14","author":"Sun","year":"2006","journal-title":"Chinese Journal of Health Psychology [\u4e2d\u56fd\u5065\u5eb7\u5fc3\u7406\u5b66\u6742\u5fd7]"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0126|cit126","unstructured":"\u5b59\u4e1c \u6c5f\u7434\u666e \u674e\u5efa\u950b \u674e\u8587 \u6768\u8001\u864e Control study on aripiprazole in the treatment of first-episode schizophrenia Chinese Journal of Health Psychology [\u4e2d\u56fd\u5065\u5eb7\u5fc3\u7406\u5b66\u6742\u5fd7] 2009 774 6"},{"issue":"12","key":"10.1002\/14651858.CD006569.pub5-BIB0127|cit127","first-page":"1416","article-title":"Quetiapine and aripiprazole in the treatment of schizophrenia] Google Translate","volume":"17","author":"\u5b59\u5fb7\u751f","year":"2009","journal-title":"Chinese Journal of Health Psychology [\u4e2d\u56fd\u5065\u5eb7\u5fc3\u7406\u5b66\u6742\u5fd7]"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub5-BIB0128|cit128","first-page":"157","article-title":"Broad effectiveness trial with aripiprazole","volume":"67","author":"Riera","year":"2004","journal-title":"Schizophrenia Research"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub5-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.schres.2005.12.857","article-title":"A prospective, multicenter, randomized, parallel-group, open-label study of aripiprazole in the management of patients with schizophrenia or schizoaffective disorder in general psychiatric practice: Broad Effectiveness Trial With aripiprazole (BETA)","volume":"84","author":"Tandon","year":"2006","journal-title":"Schizophrenia Research"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub5-BIB0130|cit130","first-page":"30","article-title":"Aripiprazole and risperidone in the treatment of female schizophrenics","volume":"18","author":"Tang","year":"2006","journal-title":"Shanghai Archives of Psychiatry [\u4e0a\u6d77\u7cbe\u795e\u533b\u5b66] [\u4e0a\u6d77\u7cbe\u795e\u91ab\u5b78]"},{"issue":"17","key":"10.1002\/14651858.CD006569.pub5-BIB0131|cit131","first-page":"727","article-title":"Comparison of efficacy and safety of aripiprazole and risperidone in the treatment of schizophrenia","volume":"19","author":"Tang","year":"2007","journal-title":"Medical Journal of Chinese People's Health [\u4e2d\u56fd\u6c11\u5eb7\u533b\u5b66]"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0132|cit132","unstructured":"Tang Q Aripiprazole and risperidone in the treatment efficacy of first-episode schizophrenia] Google Translate Chinese Journal of Pharmaco Epidemiology [\u836f\u7269\u6d41\u884c\u75c5\u5b66\u6742\u5fd7] 2010 13-4, 20"},{"issue":"17","key":"10.1002\/14651858.CD006569.pub5-BIB0133|cit133","first-page":"2243","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia] Google Translate","volume":"22","author":"\u5510\u9759","year":"2010","journal-title":"Medical Journal of Chinese People's Health [\u4e2d\u56fd\u6c11\u5eb7\u533b\u5b66]"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0134|cit134","first-page":"927","article-title":"A comparison of the effects on lipid metabolic among four different atypical antipsychotic agents","volume":"6","author":"Tao","year":"2008","journal-title":"Journal of the Youjiang Medical College for Nationalities"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub5-BIB0135|cit135","first-page":"7","article-title":"Control study of aripiprazole and risperidone in the treatment of schizophrenia","volume":"13","author":"Tong","year":"2007","journal-title":"Journal of Clinical Psychosomatic Diseases [\u4e34\u5e8a\u5fc3\u8eab\u75be\u75c5\u6742\u5fd7]"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0136|cit136","unstructured":"\u6d82\u56fd\u548c \u80e1\u6709\u5e73 \u5468\u5b66\u513f Aripiprazole (Booz Qing) and risperidone in the treatment of schizophrenia in the clinical control study] Google Translate Jiangxi Medical Journal [\u6c5f\u897f\u533b\u836f] 2009 799 800"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub5-BIB0137|cit137","first-page":"301","article-title":"A controlled study of aripiprazole vs clozapine in the treatment of first-episode schizophrenia","volume":"11","author":"Wang","year":"2005","journal-title":"Journal of Clinical Psychosomatic Diseases [\u4e34\u5e8a\u5fc3\u8eab\u75be\u75c5\u6742\u5fd7]"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub5-BIB0138|cit138","first-page":"44","article-title":"Comparative study between aripiprazole and clozapine in the treatment of patients with schizophrenia","volume":"16","author":"Wang","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub5-BIB0139|cit139","first-page":"427","article-title":"Observation of therapeutic effect of aripiprazole in the treatment schizophrenic patients","volume":"14","author":"Wang","year":"2006","journal-title":"Chinese Journal of Health Psychology [\u4e2d\u56fd\u5065\u5eb7\u5fc3\u7406\u5b66\u6742\u5fd7]"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0140|cit140","unstructured":"Wang G-P Effect of aripiprazole on quality of life of schizophrenic patients Linchuang Jingshen Yixue Zazhi [\u4e34\u5e8a\u7cbe\u795e\u533b\u5b66\u6742\u5fd7] 2006 360 1"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub5-BIB0141|cit141","first-page":"650","article-title":"A comparative study between aripiprazole and risperidone in the treatment of chronic schizophrenia","volume":"14","author":"Wang","year":"2006","journal-title":"Chinese Journal of Health Psychology [\u4e2d\u56fd\u5065\u5eb7\u5fc3\u7406\u5b66\u6742\u5fd7]"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub5-BIB0142|cit142","first-page":"245","article-title":"A controlled study of aripiprazole and risperidone in the treatment of schizophrenia","volume":"12","author":"Wang","year":"2006","journal-title":"Journal of Clinical Psychosomatic Diseases [\u4e34\u5e8a\u5fc3\u8eab\u75be\u75c5\u6742\u5fd7]"},{"issue":"17","key":"10.1002\/14651858.CD006569.pub5-BIB0143|cit143","first-page":"751","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia","volume":"19","author":"Wang","year":"2007","journal-title":"Medical Journal of Chinese People's Health [\u4e2d\u56fd\u6c11\u5eb7\u533b\u5b66]"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0144|cit144","unstructured":"Wang L-Z Weng J-Z Zhuo Z-M Comparative study on aripiprazole and risperidone in treatment of female schizophrenia \u897f\u90e8\u533b\u5b66 2007 42 3"},{"issue":"11","key":"10.1002\/14651858.CD006569.pub5-BIB0145|cit145","first-page":"44","article-title":"A force of aripiprazole and risperidone in the treatment of schizophrenia","volume":"4","author":"\u738b\u5b66\u6ee8","year":"2007","journal-title":"\u4e2d\u5916\u5065\u5eb7\u6587\u6458 [\u533b\u836f\u5b66\u520a]"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub5-BIB0146|cit146","first-page":"110","article-title":"Aripiprazole in the treatment of schizophrenia clinical observation","volume":"21","author":"\u738b\u56fd\u5bcc","year":"2007","journal-title":"Journal of the Changzhi Medical College"},{"issue":"21","key":"10.1002\/14651858.CD006569.pub5-BIB0147|cit147","first-page":"38","article-title":"A controlled study of effect on schizophrenia serum prolactin level aripiprazole","volume":"3","author":"Wang","year":"2008","journal-title":"\u4e2d\u56fd\u5b9e\u7528\u533b\u836f"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub5-BIB0148|cit148","first-page":"206","article-title":"Ziprasidone treatment of schizophrenia with predominantly negative symptoms","volume":"18","author":"\u738b\u5929\u9f99","year":"2008","journal-title":"Linchuang Jingshen Yixue Zazhi [\u4e34\u5e8a\u7cbe\u795e\u533b\u5b66\u6742\u5fd7]"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0149|cit149","unstructured":"\u738b\u8302\u840d New antipsychotic drug aripiprazole on glucose metabolism and glycosylated hemoglobin Hebei Medical Journal 2009 1752 3"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub5-BIB0151|cit150","first-page":"511","article-title":"A randomized, double blind, double dummy parallel controlled study in the female first-episode schizophrenia treated with aripiprazole and quetiapine","volume":"32","author":"Wei","year":"2006","journal-title":"Chinese Journal of Nervous and Mental Diseases"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0150|cit151","unstructured":"\u97e9\u6811\u534e Aripiprazole and quetiapine in the treatment of schizophrenia control study of women] Google Translate Medical Journal of Chinese People's Health [\u4e2d\u56fd\u6c11\u5eb7\u533b\u5b66] 2010 511 6"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub5-BIB0152|cit152","first-page":"80","article-title":"Control study of aripiprazole and clozapine in schizophrenia affect the quality of life in patients with","volume":"20","author":"\u9b4f\u6708\u73b2","year":"2007","journal-title":"Sichuan Mental Health [\u56db\u5ddd\u7cbe\u795e\u536b\u751f]"},{"issue":"16","key":"10.1002\/14651858.CD006569.pub5-BIB0153|cit153","first-page":"166","article-title":"Olanzapine A Leekpai azole treatment of schizophrenia","volume":"4","author":"\u9b4f\u4e3d\u971e","year":"2009","journal-title":"\u4e2d\u56fd\u5b9e\u7528\u533b\u836f"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub5-BIB0154|cit154","first-page":"987","article-title":"aripiprazole and risperidone in the treatment of female controlled study of schizophrenia] Google Translate","volume":"30","author":"\u6587\u542f\u7434","year":"2009","journal-title":"Guangdong Medical Journal [\u5e7f\u4e1c\u533b\u5b66]"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub5-BIB0155|cit155","first-page":"342","article-title":"Comparison of aripiprazole and risperidone in the treatment of female schizophrenia","volume":"24","author":"\u6587\u5bb6\u677e","year":"2009","journal-title":"Journal of the North Sichuan Medical College"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0156|cit156","unstructured":"Sanchez R Kostic D Stock E Torbeyns AF Kerselaers W Nyilas M Aripiprazole vs olanzapine in patients with acutely relapsing or chronic, stable schizophrenia: A 52-week open-label extension study Proceedings of the 13th Biennial Winter Workshop on Schizophrenia Research; 2006 Feb 4-10; Davos, Switzerland 2006"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub5-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00213-006-0564-3","article-title":"Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine","volume":"189","author":"Wlodzimierz","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0158|cit158","unstructured":"Beuzen J-N Pans M Modell S Hagens P McQuade R Iwamato T Broad effectiveness trial with aripiprazole in Europe Eu-Beta Proceedings of the 13th Congress of the Association of European Psychiatrists; 2005 Apr 2-6; Munich, Germany 2005"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0159|cit159","unstructured":"Beuzen J-N Pans M Modell S Hagens P McQuade R Iwamoto T Naturalistic study of aripiprazole treatment Proceedings of the XIII World Congress of Psychiatry; 2005 Sep 10-15; Cairo, Egypt 2005"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0160|cit160","unstructured":"Beuzen J-N Schirr K Pans M Hagens P Kostic D Carson W Effectiveness of aripiprazole in a naturalistic setting: a European multicenter study Proceedings of the 13th Biennial Winter Workshop on Schizophrenia Research; 2006 Feb 4-10; Davos, Switzerland 2006"},{"issue":"10","key":"10.1002\/14651858.CD006569.pub5-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1185\/030079907X225448","article-title":"A prospective, multi centre, open-label study of aripiprazole in the management of patients with schizophrenia in psychiatric practice in Europe: Broad Effectiveness Trial with aripiprazole in Europe (EU-BETA)","volume":"23","author":"Wolf","year":"2007","journal-title":"Current Medical Research and Opinion"},{"issue":"15","key":"10.1002\/14651858.CD006569.pub5-BIB0162|cit162","first-page":"1723","article-title":"A comparative study of aripiprazole and risperidone in the treamtment of senile schizophrenia","volume":"20","author":"Wu","year":"2008","journal-title":"Medical Journal of Chinese People's Health [\u4e2d\u56fd\u6c11\u5eb7\u533b\u5b66]"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0163|cit163","unstructured":"Xiao G-C Wang D-P Huang G-P Comparative study on the clinical effect and the life quality of schizophrenic patients treated with aripiprazol and clozepine \u4e2d\u56fd\u533b\u7597\u524d\u6cbf 2007 28 9"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0164|cit164","unstructured":"\u8c22\u65b0\u5e74 \u8212\u4eba\u4e5d \u94a6\u6843\u6843 Aripiprazole and risperidone in the treatment of male schizophrenia efficacy and sexual function Hunan Medical Journal 2008 1111 3"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0165|cit165","unstructured":"\u8c22\u6839\u751f \u8d75\u65b0\u857e \u94b1\u56fd\u5e73 \u5434\u7389\u7ea2 \u80e1\u5e86\u82ac Aripiprazole and risperidone in the treatment of schizophrenia] Google Translate \u4e2d\u56fd\u9884\u9632\u533b\u5b66\u6742\u5fd7 2010 190 2"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0166|cit166","unstructured":"\u5f90\u7f8e\u52e4 Aripiprazole and clozapine treatment of schizophrenia analysis Journal of Clinical Psychosomatic Diseases [\u4e34\u5e8a\u5fc3\u8eab\u75be\u75c5\u6742\u5fd7] 2007 548 9"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0167|cit167","unstructured":"\u5f90\u7b60 \u674e\u671d \u738b\u6167\u82b3 \u674e\u534e\u82b3 Aripiprazole and risperidone in the treatment of schizophrenia randomized double-blind controlled study] Google Translate Linchuang Jingshen Yixue Zazhi [\u4e34\u5e8a\u7cbe\u795e\u533b\u5b66\u6742\u5fd7] 2010 35 7"},{"issue":"11C","key":"10.1002\/14651858.CD006569.pub5-BIB0168|cit168","first-page":"15","article-title":"Aripiprazole impact on the quality of life of patients with schizophrenia","volume":"5","author":"\u960e\u7f8e\u82f1","year":"2007","journal-title":"\u5bb6\u5ead\u62a4\u58eb"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub5-BIB0169|cit169","first-page":"465","article-title":"Aripiprazole and risperidone in the treatment of children with schizophrenia","volume":"27","author":"\u95eb\u51e4\u5a1f","year":"2008","journal-title":"\u4e2d\u56fd\u533b\u5b66\u6587\u6458 [\u513f\u79d1\u5b66]"},{"issue":"18","key":"10.1002\/14651858.CD006569.pub5-BIB0170|cit170","first-page":"4304","article-title":"Aripiprazole and clozapine treatment of refractory schizophrenia","volume":"8","author":"\u95eb\u5b9d\u660c","year":"2008","journal-title":"Chinese Journal of Misdiagnostics [\u4e2d\u56fd\u8bef\u8bca\u5b66\u6742\u5fd7]"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0171|cit171","unstructured":"\u664f\u6842\u840d \u6731\u5fd7\u96fe \u4e01\u5bd2\u6625 \u6768\u6625\u9713 Aripiprazole and risperidone in patients with first-episode schizophrenia comparative efficacy and safety study] Google Translate \u4e2d\u56fd\u5f53\u4ee3\u533b\u836f 2010 37 9"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub5-BIB0172|cit172","first-page":"92","article-title":"A comparative between aripiprazole and clozapine in the treatment of schizophrenia","volume":"19","author":"Yang","year":"2006","journal-title":"Sichuan Mental Health [\u56db\u5ddd\u7cbe\u795e\u536b\u751f]"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0173|cit173","unstructured":"Yang T-R Song B-L Yuan C-Q Control study of aripiprazole and clozapine in treatment of patients with schizophrenia \u897f\u90e8\u533b\u5b66 2007 234 5"},{"issue":"23","key":"10.1002\/14651858.CD006569.pub5-BIB0174|cit174","first-page":"2760","article-title":"A comparative study of ziprasidone and aripiprazole in the treatment of schizophrenia","volume":"20","author":"Yang","year":"2008","journal-title":"Medical Journal of Chinese People's Health [\u4e2d\u56fd\u6c11\u5eb7\u533b\u5b66]"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub5-BIB0175|cit175","first-page":"52","article-title":"Study of aripiprazole in treatment of first-episode schizophrenia","volume":"17","author":"Yang","year":"2008","journal-title":"China Pharmaceuticals [\u4e2d\u570b\u85e5\u696d]"},{"issue":"13","key":"10.1002\/14651858.CD006569.pub5-BIB0176|cit176","first-page":"100","article-title":"Aripiprazole in the treatment of female schizophrenia","volume":"46","author":"a\u6768\u8363","year":"2008","journal-title":"\u4e2d\u56fd\u73b0\u4ee3\u533b\u751f"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0177|cit177","unstructured":"\u6768\u6625\u5f3a \u674e\u5b9d\u73e0 Aripiprazole and olanzapine on body weight, blood glucose control study effects of] Google Translate Linchuang Jingshen Yixue Zazhi [\u4e34\u5e8a\u7cbe\u795e\u533b\u5b66\u6742\u5fd7] 2009 339 40"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub5-BIB0178|cit178","first-page":"616","article-title":"A comparative study between aripiprazole and risperidone in treatment of first-onset schizophrenia","volume":"15","author":"Ye","year":"2005","journal-title":"Medical Journal of National Defending Forces in Southwest China"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0179|cit179","unstructured":"Ye C-W Pan D-J Ni X-J Pan J-L Zhu G-D Controlled study between aripiprazole and olanzapine on schizophrenia Modern Research of Integrated Chinese and Western Medicine [\u73b0\u4ee3\u4e2d\u897f\u533b\u7ed3\u5408\u6742\u5fd7] 2005 3199 200"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0180|cit180","unstructured":"Yi F Zhen D L-L Wang J-L Xu L-F Yang G-P A comparative study of blood2glucose metabolism between aripiprazole and clozapine in treatment of patientswith schizophrenia Journal of Clinical Psychological Medicine [\u4e34\u5e8a\u7cbe\u795e\u533b\u5b66\u6742\u5fd7] 2007 253"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub5-BIB0181|cit181","first-page":"263","article-title":"The study of clinical efficacy of aripiprazole in the treatment for refractory schizophrenia","volume":"19","author":"Yu","year":"2006","journal-title":"Shandong Jingshen Yixue"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub5-BIB0182|cit182","first-page":"422","article-title":"Effects of aripiprazole vs. clozapine on body weight and blood sugar levels of schizophrenics","volume":"12","author":"Yu","year":"2006","journal-title":"Journal of Clinical Psychosomatic Diseases [\u4e34\u5e8a\u5fc3\u8eab\u75be\u75c5\u6742\u5fd7]"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub5-BIB0183|cit183","first-page":"115","article-title":"A control study of aripirazole and clozapine in the treatment of first-episode schizophrenia","volume":"13","author":"Yu","year":"2007","journal-title":"Journal of Clinical Psychosomatic Diseases [\u4e34\u5e8a\u5fc3\u8eab\u75be\u75c5\u6742\u5fd7]"},{"issue":"19","key":"10.1002\/14651858.CD006569.pub5-BIB0184|cit184","first-page":"2267, 2269","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia","volume":"20","author":"\u4e8e\u6c38\u6d9b","year":"2008","journal-title":"Medical Journal of Chinese People's Health [\u4e2d\u56fd\u6c11\u5eb7\u533b\u5b66]"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub5-BIB0185|cit185","first-page":"211","article-title":"Aripiprazole and clozapine in the treatment of chronic schizophrenia] Google Translate","volume":"23","author":"\u4f59\u745e\u9ad8","year":"2009","journal-title":"Medical Journal of Liaoning"},{"issue":"12","key":"10.1002\/14651858.CD006569.pub5-BIB0186|cit186","first-page":"1066","article-title":"Controlled clinical studies of aripiprazole and clozapine in the treatment of schizophrenia","volume":"19","author":"\u4f59\u5fd7\u521a","year":"2007","journal-title":"Medical Journal of Chinese People's Health [\u4e2d\u56fd\u6c11\u5eb7\u533b\u5b66]"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0187|cit187","unstructured":"Zhang Y Li G An B Aripiprazole and risperidone in the treatment of schizophrenia Chinese Journal of Health Psychology [\u4e2d\u56fd\u5065\u5eb7\u5fc3\u7406\u5b66\u6742\u5fd7] 2006 635 6"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub5-BIB0188|cit188","first-page":"429","article-title":"A comparative study of aripiprazole versus olanzapine in the treatment of chronic schizophrenia","volume":"14","author":"Zhang","year":"2006","journal-title":"Chinese Journal of Health Psychology [\u4e2d\u56fd\u5065\u5eb7\u5fc3\u7406\u5b66\u6742\u5fd7]"},{"issue":"12","key":"10.1002\/14651858.CD006569.pub5-BIB0189|cit189","first-page":"1016, 1018","article-title":"A comparative study of EKG changed by aripiprazole and clozapine in the treatment of schizophrenia","volume":"19","author":"Zhang","year":"2007","journal-title":"Medical Journal of Chinese People's Health [\u4e2d\u56fd\u6c11\u5eb7\u533b\u5b66]"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub5-BIB0190|cit190","first-page":"122","article-title":"A control study of aripiprazole in the treatment of childhood schizophrenia","volume":"13","author":"Zhang","year":"2007","journal-title":"Journal of Clinical Psychosomatic Diseases [\u4e34\u5e8a\u5fc3\u8eab\u75be\u75c5\u6742\u5fd7]"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub5-BIB0191|cit191","first-page":"494","article-title":"Clinical control study of aripiprazole and risperidone in the treatment of first- episode schizophrenia","volume":"23","author":"Zhang","year":"2007","journal-title":"Modern Medicine and Health [\u73b0\u4ee3\u533b\u836f\u536b\u751f]"},{"issue":"13","key":"10.1002\/14651858.CD006569.pub5-BIB0192|cit192","first-page":"1542","article-title":"Comparative investigation on aripiprazole and risperidone in the treatment of schizophrenia","volume":"29","author":"Zhang","year":"2008","journal-title":"Journal of Qiqihar Medical College [Qiqihar Yixueyuan xuebao][\u9f4a\u9f4a\u54c8\u723e\u91ab\u5b78\u9662\u5b78\u5831]"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub5-BIB0193|cit193","first-page":"52","article-title":"Controlled clinical observation of aripiprazole and risperidone in the treatment of schizophrenia","volume":"39","author":"\u5f20\u632f\u4e1c","year":"2008","journal-title":"Guangzhou Medical Journal"},{"issue":"20","key":"10.1002\/14651858.CD006569.pub5-BIB0194|cit194","first-page":"2386, 2435","article-title":"Comparison of the efficacy of aripiprazole and risperidone in the treatment of schizophrenia","volume":"20","author":"\u5f20\u80dc\u5229","year":"2008","journal-title":"Medical Journal of Chinese People's Health [\u4e2d\u56fd\u6c11\u5eb7\u533b\u5b66]"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0195|cit195","unstructured":"\u5f20\u8273\u7426 \u4e8e\u632f\u4e1c Aripiprazole and clozapine in treatment refractory schizophrenia comparative observation] Google Translate People's Military Surgeon [\u4eba\u6c11\u519b\u533b] 2009 822 3"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub5-BIB0196|cit196","first-page":"343","article-title":"Aripiprazole and risperidone on glucose and lipid] Google Translate","volume":"19","author":"\u5f20\u4e1c\u536b","year":"2009","journal-title":"Linchuang Jingshen Yixue Zazhi [\u4e34\u5e8a\u7cbe\u795e\u533b\u5b66\u6742\u5fd7]"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub5-BIB0197|cit197","first-page":"41","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia] Google Translate","volume":"25","author":"\u5f20\u7075\u5a25","year":"2009","journal-title":"Journal of Baotou Medical College [\u5305\u982d\u91ab\u5b78\u9662\u5b78\u5831]"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0198|cit198","unstructured":"\u5f20\u542f\u6797 \u7fdf\u6c5f Aripiprazole and clozapine in treatment refractory schizophrenia] Google Translate West China Medical Journal [\u534e\u897f\u533b\u5b66] 2010 1033 5"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub5-BIB0199|cit199","first-page":"762","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia comparative analysis of 100 cases] Google Translate","volume":"18","author":"\u5f20\u7389\u6e05","year":"2010","journal-title":"Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease [\u5b9e\u7528\u5fc3\u8111\u80ba\u8840\u7ba1\u75c5\u6742\u5fd7]"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub5-BIB0200|cit200","first-page":"663","article-title":"A controlled study of aripiprazole versus quetiapine in the treatment of first-episode schizophrenia","volume":"14","author":"Zhao","year":"2006","journal-title":"Chinese Journal of Health Psychology [\u4e2d\u56fd\u5065\u5eb7\u5fc3\u7406\u5b66\u6742\u5fd7]"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub5-BIB0201|cit201","first-page":"195","article-title":"A comparative study of aripiprazole versus risperdal in patients with schizophrenia","volume":"19","author":"Zhao","year":"2007","journal-title":"Medical Journal of Chinese People's Health [\u4e2d\u56fd\u6c11\u5eb7\u533b\u5b66]"},{"issue":"21","key":"10.1002\/14651858.CD006569.pub5-BIB0202|cit202","first-page":"2787","article-title":"Comparison study of aripiprazole and risperidone on schizophrenia","volume":"14","author":"Zhi","year":"2005","journal-title":"Modern Jorunal of Integrated Traditional Chinese and Western Medicine"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0203|cit203","unstructured":"\u5468\u5e73 \u5218\u8054\u7426 Aripiprazole and clozapine treatment of schizophrenia Linchuang Jingshen Yixue Zazhi [\u4e34\u5e8a\u7cbe\u795e\u533b\u5b66\u6742\u5fd7] 2007 126 7"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub5-BIB0204|cit204","first-page":"384","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia control observation","volume":"29","author":"\u5468\u4f1f\u4e1c","year":"2007","journal-title":"Journal of the Youjiang Medical College for Nationalities"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub5-BIB0205|cit205","first-page":"354, 356","article-title":"Aripiprazole impact on the quality of life in patients with schizophrenia","volume":"19","author":"\u5468\u96e8\u6797","year":"2007","journal-title":"Medical Journal of Chinese People's Health [\u4e2d\u56fd\u6c11\u5eb7\u533b\u5b66]"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub5-BIB0206|cit206","first-page":"139","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia","volume":"21","author":"\u5468\u52c7","year":"2008","journal-title":"\u7cbe\u795e\u533b\u5b66\u6742\u5fd7"},{"issue":"10","key":"10.1002\/14651858.CD006569.pub5-BIB0207|cit207","first-page":"1194","article-title":"Clinical study of therapeutic effects of aripiprazole in treatment of patients with schizophrenia","volume":"10","author":"Zhu","year":"2005","journal-title":"Chinese Journal of Clinical Pharmacology and Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub5-BIB0208|cit208","first-page":"536","article-title":"Treatment of 40 cases of schizophrenia with aripiprazole","volume":"25","author":"Zhu","year":"2006","journal-title":"Herald of Medicine [\u533b\u836f\u5bfc\u62a5] [\u91ab\u85e5\u5c0e\u5831]"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub5-BIB0209|cit209","first-page":"9","article-title":"A Leekpai azole quetiapine controlled study for the treatment of schizophrenia","volume":"8","author":"\u6731\u6ee1\u8fde","year":"2008","journal-title":"Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine [\u5b9e\u7528\u4e2d\u897f\u533b\u7ed3\u5408\u4e34\u5e8a]"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0210|cit210","unstructured":"\u6731\u9038\u6eaa Risperidone and olanzapine and aripiprazole on cognitive function in chronic schizophrenia] Google Translate \u4e2d\u534e\u4e34\u5e8a\u533b\u5e08\u6742\u5fd7(\u7535\u5b50\u7248) 2010 1709 12"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0211|cit211","unstructured":"Pfizer A study comparing the efficacy and safety of ziprasidone and aripiprazole for the treatment of schizophrenia or schizoaffective disorder in hospitalized patients http:\/\/www.clinicaltrials.gov 2008"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub5-BIB0212|cit212","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/YIC.0b013e32816f7779","article-title":"Comparison of ziprasidone and aripiprazole in acutely ill patients with schizophrenia or schizoaffective disorder: A randomized, double-blind, 4-week study","volume":"22","author":"Zimbroff","year":"2007","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0213|cit213","unstructured":"Zou K-Q Jiang Q-L Wang D Comparative study on effects of aripiprazole and clozapine \u4e2d\u534e\u73b0\u4ee3\u5185\u79d1\u5b66\u6742\u5fd7 2006 17 9"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub5-BIB0214|cit214","first-page":"53","article-title":"Comparison study in the treatment of schizophrenia between aripiprazole and clozapine","volume":"18","author":"Ai","year":"2008","journal-title":"Linchuang Jingshen Yixue Zazhi [\u4e34\u5e8a\u7cbe\u795e\u533b\u5b66\u6742\u5fd7]"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub5-BIB0215|cit215","first-page":"418","article-title":"Similar rates of agitation, anxiety and insomnia in sedating and non-sedating antipsychotics: evaluating clinical trial results with aripiprazole, haloperidol and olanzapine","volume":"33","author":"Allen","year":"2007","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0216|cit216","unstructured":"Anon Effectiveness of antipsychotic combination with psychosocial intervention on outcome of patients with schizophrenia http:\/\/www.clinicaltrials.gov 2008"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub5-BIB0217|cit217","first-page":"198","article-title":"The effectiveness of aripiprazole combined with clonazepam treated with agitation in schizophrenia","volume":"19","author":"Bao","year":"2007","journal-title":"Medical Journal of Chinese People's Health"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0218|cit218","unstructured":"Bergman M Friedman JI Stawarz K Bowman A Siever L Cavagna M A double blind placebo controlled study of guanfacine adjunctive treatment to atypical antipsychotics for cognitive dysfunction in schizophrenia http:\/\/www.clinicaltrials.gov 2007"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0219|cit219","unstructured":"Bristol-Myers Squibb Otsuka America Pharmaceutical A multicenter, randomized, double-blind, placebo-controlled, 16 week study of aripiprazole used as dual therapy in the treatment of patients with chronic stable schizophrenia or schizoaffective disorder demonstrating an inadequate response to quetiapine or risperidone monotherapy http:\/\/www.clinicaltrials.gov 2006"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD006569.pub5-BIB0220|cit220","doi-asserted-by":"crossref","first-page":"S309","DOI":"10.1016\/S0924-977X(00)80358-2","article-title":"Efficacy of aripiprazole in psychotic disorders: comparison with haloperidol and placebo","volume":"10","author":"Carson","year":"2000","journal-title":"European Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0221|cit221","unstructured":"Casey D L'Italien G Waldeck R Cislo P Carson W Metabolic syndrome comparison between olanzapine, aripiprazole, and placebo Proceedings of the 156th Annual Meeting of the American Psychiatric Association; 2003 May 17- 22; San Francisco, California, USA 2003"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0222|cit222","first-page":"845","article-title":"A multi centre, randomised and double-blind controlled trial of aripiprazole in treatment of schizophrenia","volume":"11","author":"Chen","year":"2005","journal-title":"Chinese Journal of New Drugs and Clinical Remedies"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub5-BIB0223|cit223","first-page":"97","article-title":"A comparative study of aripiprazole and clozapine in the treatment of first-episode schizophrenia","volume":"20","author":"Chen","year":"2007","journal-title":"Shandong Archives of Psychiatry [\u5c71\u4e1c\u7cbe\u795e\u533b\u5b66]"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub5-BIB0224|cit224","first-page":"394","article-title":"A comparative study of aripiprazole and risperidone in the treatment of the first episode schizophrenia","volume":"20","author":"Chen","year":"2008","journal-title":"Medical Journal of Chinese People's Health [\u4e2d\u56fd\u6c11\u5eb7\u533b\u5b66]"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub5-BIB0225|cit225","first-page":"140","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia compared] Google Translate","volume":"16","author":"\u9648\u8389\u6676","year":"2010","journal-title":"\u5f53\u4ee3\u533b\u5b66"},{"issue":"9B","key":"10.1002\/14651858.CD006569.pub5-BIB0226|cit226","first-page":"1232","article-title":"Aripiprazole and risperidone in the treatment of female schizophrenia] Google Translate","volume":"19","author":"\u9648\u6c38\u7ea2","year":"2010","journal-title":"Shanxi Clinical Medicine"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub5-BIB0227|cit227","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2147\/NDT.S3701","article-title":"An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia","volume":"4","author":"Colombo","year":"2008","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD006569.pub5-BIB0228|cit228","first-page":"27","article-title":"Neurocognitive effects of aripiprazole versus olanzapine in patients with stable psychosis","volume":"53","author":"Cornblatt","year":"2002","journal-title":"Schizophrenia Research"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006569.pub5-BIB0229|cit229","first-page":"NRS5.4","article-title":"Aripiprazole, olanzapine and olanzapine-clomipramine combination in schizophrenia with obsessive-compulsive symptoms","volume":"8","author":"Fawzi","year":"2009","journal-title":"World Psychiatry"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0230|cit230","doi-asserted-by":"crossref","first-page":"S447","DOI":"10.1016\/S0924-977X(08)70660-6","article-title":"Long-term effect on weight of aripiprazole-clozapine in schizophrenia patients with suboptimal response on clozapine","volume":"18","author":"Fleischhacker","year":"2008","journal-title":"European Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0231|cit231","unstructured":"Markovic O A multicenter, comparative, randomized, double-blind, placebo controlled study on the effect on weight of adjunctive treatment with aripiprazole in patients with schizophrenia http:\/\/www.clinicaltrials.gov 2006"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0232|cit232","unstructured":"\u803f\u5bd2\u677e \u5218\u8363\u82b9 \u8fb9\u8f9b\u4e11 \u82cf\u79c0\u8339 \u5d14\u6625\u9752 \u848b\u9f99 Comparative study of the effects of ariplprazole and risoeridone on the therapeutic effect and patients\u2019weight in patients with schizophrenia Hebei Medical Journal 2009 407 9"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub5-BIB0233|cit233","first-page":"241","article-title":"A controlled study of efficacy between aripiprazole and risperidone in the treatment of patients with","volume":"17","author":"Guan","year":"2007","journal-title":"Linchuang Jingshen Yixue Zazhi [\u4e34\u5e8a\u7cbe\u795e\u533b\u5b66\u6742\u5fd7]"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0234|cit234","unstructured":"\u97e9\u60e0\u82ac Second generation of psychiatric drugs 3 cost of the treatment of schizophrenia] Google Translate Journal of Qiqihar Medical College [Qiqihar Yixueyuan xuebao][\u9f4a\u9f4a\u54c8\u723e\u91ab\u5b78\u9662\u5b78\u5831] 2010 1379 80"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub5-BIB0235|cit235","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.schres.2009.05.030","article-title":"Effectiveness of second-generation antipsychotics with acute-phase schizophrenia","volume":"113","author":"Hatta","year":"2009","journal-title":"Schizophrenia Research"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub5-BIB0236|cit236","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/JCP.0b013e31819a8dbe","article-title":"Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients","volume":"29","author":"Henderson","year":"2009","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0237|cit237","unstructured":"Roussel JJ Machon DA Henderson DC A placebo-controlled, cross-over trial of aripiprazole added to obese olanzapine-treated patients with schizophrenia http:\/\/www.clinicaltrials.gov 2006"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub5-BIB0238|cit238","first-page":"77","article-title":"Clinical efficacy of aripiprazole and risperidone in treating schizophrenia and their influence","volume":"10","author":"Huang","year":"2008","journal-title":"\u836f\u7269\u4e0d\u826f\u53cd\u5e94\u6742\u5fd7"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0239|cit239","unstructured":"Janssen F A comparative, randomized, open-label, multicenter study on the efficacy and safety of switch treatment with aripiprazole in schizophrenic out-patients who are experiencing insufficient efficacy with risperidone and\/or safety and tolerability issues, while on risperidone http:\/\/www.clinicaltrials.gov 2005"},{"issue":"10","key":"10.1002\/14651858.CD006569.pub5-BIB0240|cit240","first-page":"1147","article-title":"A comparison between the therapeutic effects of aripiprazole and risperidone in the treatment of schizophrenia","volume":"26","author":"Jiang","year":"2007","journal-title":"Herald of Medicine [\u533b\u836f\u5bfc\u62a5] [\u91ab\u85e5\u5c0e\u5831]"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub5-BIB0241|cit241","first-page":"39","article-title":"Comparative analysis of aripiprazole and risperidone in the treatment of schizophrenia negative emotions","volume":"22","author":"\u97a0\u5eb7","year":"2009","journal-title":"Sichuan Mental Health [\u56db\u5ddd\u7cbe\u795e\u536b\u751f]"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0242|cit242","unstructured":"Kim YS A double-blind randomized placebo controlled study of aripiprazole augmentation for clozapine-treated patients with refractory schizophrenia http:\/\/www.clinicaltrials.gov 2006"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0243|cit243","unstructured":"Kim C-Y A multi-center, randomized, open, treatment-switching study from orally administered antipsychotic monotherapy in the treatment of chronic schizophrenic and schizoaffective patients http:\/\/www.clinicaltrials.gov 2006"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub5-BIB0244|cit244","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/YIC.0b013e32832c25d7","article-title":"A 12-week, naturalistic switch study of the efficacy and tolerability of aripiprazole in stable outpatients with schizophrenia or schizoaffective disorder","volume":"24","author":"Kim","year":"2009","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0245|cit245","doi-asserted-by":"crossref","first-page":"S440","DOI":"10.1016\/S0924-977X(08)70647-3","article-title":"Prolactin level as an indicator to clinical psychopathological severity in aripiprazole treated schizophrenia","volume":"18","author":"Lan","year":"2008","journal-title":"European Neuropsychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub5-BIB0246|cit246","first-page":"165","article-title":"A controlled study of domestic aripiprazole and clozapine in the treatment of refractory schizophrenia","volume":"19","author":"Li","year":"2007","journal-title":"Medical Journal of Chinese People's Health [\u4e2d\u56fd\u6c11\u5eb7\u533b\u5b66]"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub5-BIB0247|cit247","first-page":"170","article-title":"A comparative study on quality of life of female schizophrenics treated with aripiprazole","volume":"19","author":"Li","year":"2007","journal-title":"Medical Journal of Chinese People's Health [\u4e2d\u56fd\u6c11\u5eb7\u533b\u5b66]"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0248|cit248","unstructured":"Liang S A multi-center, randomized, double-blind study, comparing with risperidone, to evaluate the efficacy and safety of aripiprazole in the treatment of patients with schizophrenia http:\/\/www.clinicaltrials.gov 2005"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0249|cit249","unstructured":"\u674e\u8d85 \u674e\u6167\u5a25 \u5218\u5f69\u79c0 Aripiprazole and clozapine in the treatment of schizophrenia were] Google Translate Acta Medicinae Sinica [\u534e\u590f\u533b\u5b66] 2010 391 3"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub5-BIB0250|cit250","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1055\/s-0031-1271688","article-title":"An open randomized pilot trial on the differential effects of aripiprazole versus risperidone on anhedonia and subjective well-being","volume":"44","author":"Liemburg","year":"2011","journal-title":"Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0251|cit251","unstructured":"Lin C A controlIed study of aripiprazole and risperidone in treatment of first-episode schizophrenia Chinese Journal of Health Psychology [\u4e2d\u56fd\u5065\u5eb7\u5fc3\u7406\u5b66\u6742\u5fd7] 2006 660 1"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0252|cit252","unstructured":"\u6797\u4e91 \u6c6a\u5b5d\u9b41 \u6e29\u8fbe\u6c11 \u9ec4\u822a Control study of aripiprazole and clozapine in the treatment of the negative symptoms of schizophrenia Sichuan Mental Health [\u56db\u5ddd\u7cbe\u795e\u536b\u751f] 2009 38 9"},{"issue":"8","key":"10.1002\/14651858.CD006569.pub5-BIB0253|cit253","first-page":"36","article-title":"A comparison study on the efficacy and safety of aripiprazole and risperidone in the treatment of schizophrenia","volume":"7","author":"Liu","year":"2007","journal-title":"Modern Hospital"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub5-BIB0254|cit254","first-page":"142","article-title":"Compared effect and safety analysis of aripiprazole in late-onset schizophrenia","volume":"20","author":"Liu","year":"2007","journal-title":"Sichuan Mental Health [\u56db\u5ddd\u7cbe\u795e\u536b\u751f]"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0255|cit255","unstructured":"\u5218\u6653\u7ea2 \u674e\u536b\u519b \u5b63\u78ca Clinical comparison of aripiprazole and risperidone in the treatment of female schizophrenia Sichuan Mental Health [\u56db\u5ddd\u7cbe\u795e\u536b\u751f] 2009 115 6"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0256|cit256","unstructured":"\u5362\u8273\u6625 \u674e\u626c Aripiprazole and risperidone in the treatment of schizophrenia Medical Journal of Chinese People's Health [\u4e2d\u56fd\u6c11\u5eb7\u533b\u5b66] 2008 2804"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub5-BIB0257|cit257","first-page":"181","article-title":"Effect of aripiprazole on body weight and blood glucose in the treatment of first-episode schizophrenia","volume":"19","author":"Lv","year":"2006","journal-title":"Shandong Archives of Psychiatry [\u5c71\u4e1c\u7cbe\u795e\u533b\u5b66]"},{"issue":"12","key":"10.1002\/14651858.CD006569.pub5-BIB0258|cit258","first-page":"1046, 1048","article-title":"A study of aripiprazole combined with clozapine in refractory schizophrenia","volume":"19","author":"Ma","year":"2007","journal-title":"Medical Journal of Chinese People's Health [\u4e2d \u56fd \u6c11 \u5eb7 \u533b \u5b66 ]"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub5-BIB0259|cit259","first-page":"77","article-title":"Comparative study on aripiprazole and risperidone in the treatment of female patients with schizophrenics","volume":"12","author":"\u9a6c\u95ef\u80dc","year":"2009","journal-title":"\u5b9e\u7528\u836f\u7269\u4e0e\u4e34\u5e8a"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0260|cit260","unstructured":"Medori R Wapenaar R De Arce R Rouillon F Gaebel W Cordes J Relapse prevention and effectiveness in schizophrenia of risperidone long-acting injectable (rlai) versus quetiapine or aripiprazole Proceedings of the 161st Annual Meeting of the American Psychiatric Association; 2008 May 3-8; Washington DC, USA 2008"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub5-BIB0261|cit261","first-page":"A17","article-title":"The effects of aripiprazole in combination with clozapine: patient functioning results from a double-blind, 16-week study in patients with schizophrenia (CN138-170)","volume":"22","author":"Millar","year":"2008","journal-title":"Journal of Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub5-BIB0262|cit262","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/ebmh.7.2.41","article-title":"Aripiprazole is effective for relapse prevention in people with chronic stable schizophrenia","volume":"7","author":"Mortimer","year":"2004","journal-title":"Evidence-Based Mental Health"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub5-BIB0263|cit263","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/FPC.0b013e328311a917","article-title":"Functional serotonin 1A receptor variant influences treatment response to atypical antipsychotics in schizophrenia","volume":"19","author":"Mossner","year":"2009","journal-title":"Pharmacogenetics and Genomics"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0264|cit264","unstructured":"Namey LB Henderson DC Aripiprazole for clozapine associated medical morbidity http:\/\/www.clinicaltrials.gov 2006"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0265|cit265","unstructured":"Newcomer JW L'Italien G Vester-Blokland McQuade RD Carson WH Marcus RN Improvement of non-hdl cholesterol levels among patients randomized to aripiprazole versus olanzapine Proceedings of the 159th Annual Meeting of the American Psychiatric Association; 2006 May 20-25; Toronto, Canada 2006"},{"issue":"2-3","key":"10.1002\/14651858.CD006569.pub5-BIB0266|cit266","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.schres.2008.09.002","article-title":"Changes in non-high-density lipoprotein cholesterol levels and triglyceride\/high-density lipoprotein cholesterol ratios among patients randomized to aripiprazole versus olanzapine","volume":"106","author":"Newcomer","year":"2008","journal-title":"Schizophrenia Research"},{"issue":"2-3","key":"10.1002\/14651858.CD006569.pub5-BIB0267|cit267","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.schres.2008.09.002","article-title":"Changes in non-high-density lipoprotein cholesterol levels and triglyceride\/high-density lipoprotein cholesterol ratios among patients randomized to aripiprazole versus olanzapine","volume":"106","author":"Newcomer","year":"2008","journal-title":"Schizophrenia Research"},{"issue":"8","key":"10.1002\/14651858.CD006569.pub5-BIB0268|cit268","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.euroneuro.2009.04.002","article-title":"Immediate versus gradual suspension of previous treatments during switch to aripiprazole: results of a randomized, open label study","volume":"19","author":"Pae","year":"2009","journal-title":"European Neuropsychopharmacology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD006569.pub5-BIB0269|cit269","doi-asserted-by":"crossref","first-page":"S279","DOI":"10.1016\/S0924-977X(04)80327-4","article-title":"An economic evaluation of aripiprazole compared to olanzapine based on metabolic side-effect profile","volume":"14","author":"Ray","year":"2004","journal-title":"Journal of the European College of Neuropsychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub5-BIB0270|cit270","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/ebmh.12.2.51","article-title":"Refractory schizophrenia: Adding aripiprazole to clozapine reduces negative but not overall symptoms","volume":"12","author":"Remington","year":"2009","journal-title":"Evidence-Based Mental Health"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0271|cit271","doi-asserted-by":"crossref","unstructured":"Schreiner A De Arce R Eding E Marques-Teixeira J Milanova V Rancans E Descriptive analyses of the aripiprazole arm in the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE) Proceedings of the 9th World Congress of Biological Psychiatry; 2009 Jun 28-Jul 2; Paris, France 2009","DOI":"10.1055\/s-0029-1240096"},{"issue":"7","key":"10.1002\/14651858.CD006569.pub5-BIB0272|cit272","first-page":"714","article-title":"A controlled study on aripiprazole and risperidone in the treatment of schizophrenic patients","volume":"23","author":"Shen","year":"2006","journal-title":"Chinese Journal of Modern Applied Pharmacy"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD006569.pub5-BIB0273|cit273","doi-asserted-by":"crossref","first-page":"S405","DOI":"10.1016\/S0924-977X(06)70504-1","article-title":"Adjunctive treatment with a dopamine partial agonist, aripiprazole for antipsychotic induced hyperprolactinemia","volume":"16","author":"Shim","year":"2006","journal-title":"European Neuropsychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub5-BIB0274|cit274","first-page":"642","article-title":"A randomized control study aripiprazole in the treatment of first-episode schizophrenia","volume":"14","author":"Sun","year":"2006","journal-title":"Chinese Journal of Health Psychology [\u4e2d\u56fd\u5065\u5eb7\u5fc3\u7406\u5b66\u6742\u5fd7]"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub5-BIB0275|cit275","first-page":"381","article-title":"Quetiapine, aripiprazole treatment efficacy in patients with acute schizophrenia] Google Translate","volume":"22","author":"\u5b59\u9e4f","year":"2009","journal-title":"Shandong Archives of Psychiatry [\u5c71\u4e1c\u7cbe\u795e\u533b\u5b66]"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub5-BIB0276|cit276","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/JCP.0b013e3181842586","article-title":"A randomized, open-label comparison of 2 switching strategies to aripiprazole treatment in patients with schizophrenia: add-on, wait, and tapering of previous antipsychotics versus add-on and simultaneous tapering","volume":"28","author":"Takeuchi","year":"2008","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0277|cit277","unstructured":"Talbott S Buckley P Eudicone J McQuade R Van-Tran Q Akathisia in schizophrenia patients treated with aripiprazole, haloperidol, or olanzapine-analyses of the first 12 weeks of three double-blind, long-term trials Proceedings of the 11th International Congress on Schizophrenia Research; 2007 Mar 28-Apr 1; Colorado Springs, Colorado, USA 2007"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub5-BIB0278|cit278","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/ebmh.10.3.76","article-title":"Haloperidol, olanzapine and risperidone reduce treatment failure compared to aripiprazole, quetiapine and ziprasidone in acute schizophrenia","volume":"10","author":"Taylor","year":"2007","journal-title":"Evidence-Based Mental Health"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0279|cit279","unstructured":"Wang X-Q Zhou H-X Zhang Y-L Wang H-Y Gao T-X Xie P-L Clinical study of aripiprazole and risperidone in treatment of schizophrenia Journal of Clinical Psychiatry 2006 108 9"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0280|cit280","unstructured":"Wang K-Q Guan H-Y Jiang L Geng H-S Li Q-X Liu Z-R A controlled study of effect on serum prolactin level between aripiprazole and risperidone Linchuang Jingshen Yixue Zazhi [\u4e34\u5e8a\u7cbe\u795e\u533b\u5b66\u6742\u5fd7] 2007 154 6"},{"issue":"32","key":"10.1002\/14651858.CD006569.pub5-BIB0281|cit281","first-page":"2487","article-title":"Non - classical antipsychotic drugs for schizophrenia: cost - minimization analysis on 3 schemes","volume":"18","author":"Wang","year":"2007","journal-title":"China Pharmacy [\u4e2d\u570b\u85e5\u623f]"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0282|cit282","unstructured":"Watts KL Wilson H Tang T Estimating and reducing the cardiovascular risk of patients with schizophrenia drugs from lipid measures and ischemic electrocardiographic changes http:\/\/www.clinicaltrials.gov 2006"},{"issue":"19","key":"10.1002\/14651858.CD006569.pub5-BIB0283|cit283","first-page":"1629","article-title":"Comparative study of aripiprazole and risperidone for schizophrenia","volume":"29","author":"Xu","year":"2008","journal-title":"Jilin Medical Journal"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub5-BIB0284|cit284","first-page":"942","article-title":"A ramdomized controlled clinical study of aripiprazole in the treatment of childhood schizophrenia","volume":"24","author":"Yang","year":"2007","journal-title":"Hunan Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub5-BIB0285|cit285","first-page":"15","article-title":"A control study of aripiprazole vs. clozapine in the treatment of refractory schizophrenia","volume":"13","author":"Yang","year":"2007","journal-title":"Journal of Clinical Psychosomatic Diseases"},{"issue":"10","key":"10.1002\/14651858.CD006569.pub5-BIB0286|cit286","first-page":"948","article-title":"Comparative study of aripiprazole and risperidone in the treatment of female schizophrenias","volume":"15","author":"Yu","year":"2007","journal-title":"Chinese Journal of Health Psychology [\u4e2d\u56fd\u5065\u5eb7\u5fc3\u7406\u5b66\u6742\u5fd7]"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub5-BIB0287|cit287","first-page":"288","article-title":"Influence of aripiprazole on life quality of the patients with schizophrenia","volume":"21","author":"Zeng","year":"2006","journal-title":"Chinese Journal of Rehabilitation [\u4e2d\u570b\u5eb7\u5fa9]"},{"issue":"9","key":"10.1002\/14651858.CD006569.pub5-BIB0288|cit288","first-page":"753","article-title":"Controlled study on aripiprazole in the treatment of schizophrenic patients who has response to clozapine","volume":"18","author":"Zhang","year":"2006","journal-title":"Medical Journal of Chinese Civil Administration"},{"issue":"11","key":"10.1002\/14651858.CD006569.pub5-BIB0289|cit289","first-page":"299","article-title":"Aripiprazole and quetiapine in the treatment control study of first-episode schizophrenia] Google Translate","volume":"17","author":"\u5f20\u5e06","year":"2009","journal-title":"Chinese Journal of Health Psychology [\u4e2d\u56fd\u5065\u5eb7\u5fc3\u7406\u5b66\u6742\u5fd7]"},{"issue":"14","key":"10.1002\/14651858.CD006569.pub5-BIB0290|cit290","first-page":"1703","article-title":"Aripiprazole and clozapine in the treatment of refractory schizophrenia","volume":"29","author":"\u5f20\u4ec1\u51ef","year":"2008","journal-title":"Journal of Qiqihar Medical College [Qiqihar Yixueyuan xuebao][\u9f4a\u9f4a\u54c8\u723e\u91ab\u5b78\u9662\u5b78\u5831]"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub5-BIB0291|cit291","first-page":"117","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia","volume":"29","author":"\u5f20\u5c0f\u8046","year":"2007","journal-title":"Fujian Medical Journal [\u798f\u5efa\u533b\u836f\u6742\u5fd7]"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub5-BIB0292|cit292","first-page":"221","article-title":"Aripiprazole and risperidone on serum prolactin levels] Google Translate","volume":"23","author":"\u8d75\u8d35\u6587","year":"2009","journal-title":"Medical Journal of Liaoning"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0293|cit293","unstructured":"\u8d75\u6676\u5a9b \u90ed\u7d20\u82b9 \u738b\u65b0\u53cb A control study on effect of domestic aripiprazole and clozapine in treatment of schizophrenia Occupation and Health [\u804c\u4e1a\u4e0e\u5065\u5eb7] 2009 666 8"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0294|cit294","unstructured":"Zhe J Shi X-Y Tan T-C Liu W-X Tao P-Y Wang J Comparative study of aripiprazole and risperidone in treatment of late onset schizophrenia Linchuang Jingshen Yixue Zazhi [\u4e34\u5e8a\u7cbe\u795e\u533b\u5b66\u6742\u5fd7] 2007 327 8"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0295|cit295","unstructured":"\u652f\u80dc\u5229 aripiprazole and risperidone in the treatment of schizophrenia compared efficacy] Google Translate China Pharmaceuticals [\u4e2d\u570b\u85e5\u696d] 2010 52 3"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub5-BIB0296|cit296","first-page":"650","article-title":"A comparative study between aripiprazole and risperidone in the treatment of chronic schizophrenia","volume":"14","author":"Wang","year":"2006","journal-title":"Chinese Journal of Health Psychology [\u4e2d\u56fd\u5065\u5eb7\u5fc3\u7406\u5b66\u6742\u5fd7]"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub5-BIB0297|cit297","first-page":"663","article-title":"A controlled study of aripiprazole versus quetiapine in the treatment of first-episode schizophrenia","volume":"14","author":"Zhao","year":"2006","journal-title":"Chinese Journal of Health Psychology [\u4e2d\u56fd\u5065\u5eb7\u5fc3\u7406\u5b66\u6742\u5fd7]"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub5-BIB0298|cit298","first-page":"457","article-title":"Aripiprazole in the treatment of schizophrenia, efficacy and safety analysis","volume":"20","author":"\u90d1\u5b5d\u8363","year":"2008","journal-title":"Modern Practical Medicine"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0299|cit299","unstructured":"\u9676\u5efa\u9752 \u6881\u4f73 \u66fe\u5f3a \u5eb7\u7ea2 A controlled study on compliance of schizophrenia treated with aripiprazole and risperidone Proceedings of the 8th National Academic Congress of CSP with the Regional Meeting of the WPA; 2007 Sep 20-23; Shanghai 2007 334"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0300|cit300","unstructured":"Bristol-Myers Squibb Metabolic abnormalities - OPT http:\/\/www.clinicaltrials.gov 2009"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0301|cit301","unstructured":"Eli Lilly Company Study of olanzapine vs aripiprazole in the treatment of schizophrenia Eli Lilly and Company Clinical Trial Registry 2003"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0302|cit302","unstructured":"Essock SM Covell NH Carbuto M Bielen K Jabbour B Saltz BL Effectiveness of switching antipsychotic medications http:\/\/www.clinicaltrials.gov 2002"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0303|cit303","unstructured":"Glorioso DK Jeste DV Metabolic effects of newer antipsychotics in older patients http:\/\/www.clinicaltrials.gov 2005"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0304|cit304","unstructured":"Hanssens L A 16-Week, multicenter, randomized, open-label study to assess the effects of aripiprazole versus other atypical antipsychotics in the treatment of schizophrenic patients with metabolic syndrome http:\/\/www.clinicaltrials.gov 2007"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0305|cit305","unstructured":"Johnson & Johnson Pharmaceutical Research & Development LLC A 2-year, prospective, blinded-rater, open-label, active-controlled, multicenter, randomized study of long-term efficacy and effectiveness comparing risperdal\u00ae consta\u00ae and abilify\u00ae (aripiprazole) in adults with schizophrenia http:\/\/www.clinicaltrials.gov 2006"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0306|cit306","unstructured":"Lehrer DS Jewell M Best event schizophrenia trial--a randomized double-blind trial of aripiprazole and risperidone in schizophrenia http:\/\/www.clinicaltrials.gov 2008"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0307|cit307","unstructured":"Lin C-C Identification and treatment response prediction of antipsychotic-related metabolic syndrome http:\/\/www.clinicaltrials.gov 2009"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0308|cit308","unstructured":"Livingston M Stroup TS McEvoy JP Rojas I Gamel N Glick I Clinical management of metabolic problems in patients with schizophrenia http:\/\/www.clinicaltrials.gov 2007"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0309|cit309","unstructured":"McCormack J Robinson D Tobias K Petrides G Robinson D Sevy S Preventing morbidity in first episode schizophrenia, part II http:\/\/www.clinicaltrials.gov 2006"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0310|cit310","unstructured":"McEvoy JP Metabolic signatures and biomarkers for aripiprazole http:\/\/www.clinicaltrials.gov 2007"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0311|cit311","unstructured":"Montoya D Blizard R Buckley PF Holman T Kerr J Miller DD Preventing relapse: oral antipsychotics compared to injectables: evaluating efficacy (PROACTIVE) http:\/\/www.clinicaltrials.gov 2006"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0312|cit312","unstructured":"Schweiger J Flavin K Rosen B Spies A Newcomer JW Haupt D Changes in adiposity and metabolic measures during medication switches to aripiprazole from other atypical antipsychotics http:\/\/www.clinicaltrials.gov 2005"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub5-BIB0313|cit313","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3371\/CSRP.1.1.6","article-title":"Comparison of antipsychotics for metabolic problems (CAMP): a NIMH schizophrenia trials network study","volume":"1","author":"Stroup","year":"2007","journal-title":"Clinical Schizophrenia and Related Psychoses"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0314|cit314","doi-asserted-by":"crossref","unstructured":"Swartz M Stroup TS McEvoy JP Rojas IA Comparison of optimal antipsychotic treatments for adults with schizophrenia http:\/\/www.clinicaltrials.gov 2008","DOI":"10.1037\/e645452010-001"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0315|cit315","unstructured":"Vontur MG Lopez J Woolsey MD Maples NL Velligan DI Do patients taking aripiprazole learn more in vocational skills training than patients taking olanzapine? http:\/\/www.clinicaltrials.gov 2005"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0316|cit316","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0317|cit317","first-page":"1","article-title":"Practice guidelines for the treatment of patients with schizophrenia","volume-title":"American Journal of Psychiatry","author":"American Psychiatric Association","year":"2004"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0318|cit318","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0893-133X(97)00112-7","article-title":"Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence","volume":"18","author":"Arnt","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0319|cit319","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"British Journal of Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD006569.pub5-BIB0320|cit320","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006622.pub2","article-title":"Aripiprazole versus placebo for schizophrenia","author":"Belgamwar Ravindra","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub5-BIB0321|cit321","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006617.pub3","article-title":"Aripiprazole versus typical antipsychotic drugs for schizophrenia","author":"Bhattacharjee","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0322|cit322","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes. Trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0323|cit323","unstructured":"British National Formulary (BNF) http:\/\/www.bnf.org\/bnf\/index.htm accessed June\/July 2013"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub5-BIB0324|cit324","first-page":"405","article-title":"The problem of therapeutic efficacy indices.3. Comparison of the indices and their use","volume":"54","author":"Boissel","year":"1999","journal-title":"Therapie"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0325|cit325","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1056\/NEJM199403103301006","article-title":"Schizophrenia","volume":"330","author":"Carpenter","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub5-BIB0326|cit326","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/01.pra.0000314317.79544.b4","article-title":"Evaluation of the use of the positive and negative syndrome scale-excited component as a criterion for administration of p. r. n. medication","volume":"14","author":"Chaichan","year":"2008","journal-title":"Journal of Psychiatric Practice"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub5-BIB0327|cit327","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006324.pub2","article-title":"Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia","author":"Cipriani","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0328|cit328","unstructured":"Deeks J Issues in the selection for meta-analyses of binary data Proceeding of the 8th International Cochrane Colloquium; 2000 Oct 25-28th; Cape Town, South Africa Cape Town Cochrane Collaboration 2000"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0329|cit329","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0330|cit330","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/sim.1301","article-title":"Issues in the meta-analysis of cluster randomized trials","volume":"21","author":"Donner","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub5-BIB0331|cit331","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001359.pub2","article-title":"Olanzapine for schizophrenia","author":"Duggan","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0332|cit332","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"13","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub5-BIB0333|cit333","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004578.pub3","article-title":"Aripiprazole for schizophrenia","author":"El-Sayeh","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub5-BIB0334|cit334","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0335|cit335","unstructured":"U. S. Federal Drug Administration CDER Abilify (aripiprazole) tablets, medical review www.fda.gov\/cder\/foi\/nda\/2002\/21-436_Abilify.htm 2002"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0336|cit336","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0337|cit337","unstructured":"Gaebel W Falkai P Weinmann S Wobrock T Treatment guidelines for schizophrenia Steinkopf 2006"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0338|cit338","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0339|cit339","volume-title":"ECDEU assessment manual for psychopharmacology","author":"Guy","year":"1976"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub5-BIB0340|cit340","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/schbul\/10.3.388","article-title":"The quality of life scale: An instrument for rating the schizophrenic deficit syndrome","volume":"10","author":"Heinrichs","year":"1984","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0341|cit341","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1176\/appi.ajp.163.2.185","article-title":"Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine","volume":"163","author":"Heres","year":"2006","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0342|cit342","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0343|cit343","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org 2011"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub5-BIB0344|cit344","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2141.2009.07707.x","article-title":"Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials","volume":"146","author":"Hutton","year":"2009","journal-title":"British Journal of Haematology"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub5-BIB0345|cit345","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4314\/cajm.v47i1.8584","article-title":"The reliability of the Shona version of the EQ-5D","volume":"47","author":"Jelsma","year":"2001","journal-title":"Central African Journal of Medicine"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0346|cit346","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.63.10.1079","article-title":"Randomized controlled trial of the effect on quality of life","volume":"63","author":"Jones","year":"2006","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0347|cit347","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment of treatment-resistant schizophrenia: a double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0348|cit348","first-page":"585","article-title":"Treatment programme and long-term outcome in chronic schizophrenia","volume":"46","author":"Kane","year":"1993","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0349|cit349","volume-title":"Positive and Negative Syndrome Scale (PANSS) Manual","author":"Kay","year":"1986"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub5-BIB0350|cit350","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1023\/A:1015081805439","article-title":"Psychometric evaluation of the impact of weight on quality of life-lite questionnaire (IWQOL-lite) in a community sample","volume":"11","author":"Kolotkin","year":"2002","journal-title":"Quality of Life Research"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0351|cit351","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","article-title":"What does the PANSS mean?","volume":"79","author":"Leucht","year":"2005","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0352|cit352","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1192\/bjp.187.4.366","article-title":"Clinical implications of brief psychiatric rating scale scores","volume":"187","author":"Leucht","year":"2005","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub5-BIB0353|cit353","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/schbul\/sbl025","article-title":"Is the superior efficacy of new generation antipsychotics an artifact of LOCF?","volume":"33","author":"Leucht","year":"2007","journal-title":"Schizophrenia Bulletin"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub5-BIB0354|cit354","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1176\/appi.ajp.2008.08030368","article-title":"A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia","volume":"166","author":"Leucht","year":"2009","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0355|cit355","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Liebermann","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub5-BIB0356|cit356","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009005","article-title":"Antipsychotic combinations for schizophrenia","author":"Maayan","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0357|cit357","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales - a major source of bias in randomised controlled trials of treatments for schizophrenia?","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0358|cit358","unstructured":"Martindale: the complete drug reference http:\/\/www.medicinescomplete.com\/mc\/martindale\/current\/ accessed June\/ July 2013"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0359|cit359","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00127-004-0762-4","article-title":"Schizophrenia and employment - a review","volume":"39","author":"Marvaha","year":"2004","journal-title":"Social Psychiatry and Psychiatric Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub5-BIB0360|cit360","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/009262300278623","article-title":"The Arizona Sexual Experience Scale (ASEX): reliability and validity","volume":"26","author":"McGahuey","year":"2000","journal-title":"Journal of Sex & Marital Therapy"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0361|cit361","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/jama.285.15.1987","article-title":"The CONSORT Statement: revised recommendations for improving the quality of reports of parallel- group randomized trials","volume":"285","author":"Moher","year":"2001","journal-title":"JAMA"},{"issue":"12","key":"10.1002\/14651858.CD006569.pub5-BIB0362|cit362","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006629.pub2","article-title":"Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems","author":"Mukundan","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0363|cit363","first-page":"329","article-title":"New assessment of atypical antipsychotics","volume":"71","author":"M\u00f6ller","year":"2000","journal-title":"Nervenarzt"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0364|cit364","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1008901320492","article-title":"A comparison of the WHOQOL-100 and the WHOQOL-BREF in detecting change in quality of life following liver transplantation","volume":"9","author":"O'Carroll","year":"2000","journal-title":"Quality of Life Research"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0365|cit365","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub5-BIB0366|cit366","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008074","article-title":"Aripiprazole for psychosis-induced aggression or agitation","author":"Pagadala","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub5-BIB0367|cit367","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1037\/0735-7028.34.1.108","article-title":"Aripiprazole: A novel antipsychotic with dopamine stabilising properties","volume":"34","author":"Rivas-Vasquez","year":"2003","journal-title":"Professional Psychology"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0368|cit368","volume-title":"Modern Psychometrics","author":"Rust","year":"1989"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0369|cit369","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/9780470712184.ch12","article-title":"Chapter 12: Interpreting results and drawing conclusions","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Sch\u00fcnemann","year":"2008"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0370|cit370","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal adverse effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"issue":"2-3","key":"10.1002\/14651858.CD006569.pub5-BIB0371|cit371","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.psychres.2005.05.006","article-title":"Validation of the investigator's assessment questionnaire, a new clinical tool for relative assessment of response to antipsychotics in patients with schizophrenia and schizoaffective disorder","volume":"136","author":"Tandon","year":"2005","journal-title":"Psychiatry Research"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0372|cit372","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2008.04.011","article-title":"Schizophrenia, \"just the facts\"What we know in 2008.2. Epidemiology and etiology","volume":"102","author":"Tandon","year":"2008","journal-title":"Schizophrenia Research"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub5-BIB0373|cit373","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jclinepi.2008.12.011","article-title":"A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers","volume":"62","author":"Thorpe","year":"2009","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0374|cit374","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/archpsyc.1978.01770260031002","article-title":"Suicide in schizophrenics, manics, depressives, and surgical controls: a comparison with general population suicide mortality","volume":"35","author":"Tsuang","year":"1978","journal-title":"Archives of General Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub5-BIB0375|cit375","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta3050","article-title":"Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review","volume":"3","author":"Ukoumunne","year":"1999","journal-title":"Health Technology Assessment"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub5-BIB0376|cit376","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002305","article-title":"Antidepressants for people with both schizophrenia and depression","author":"Whitehead","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0377|cit377","volume-title":"The World Health Report 2001 - Mental Health: New Understanding, New Hope","author":"WHO","year":"2001"},{"key":"10.1002\/14651858.CD006569.pub5-BIB0378|cit378","unstructured":"Xia J Adams CE Bhagat N Bhagat V Bhoopathi P El-Sayeh H The Leeds Outcomes Stakeholders Survey (LOSS) study Proceedings of the 15th Cochrane Colloquium, Sao Paulo, 23-27 October 2007 2007"},{"issue":"7","key":"10.1002\/14651858.CD006569.pub5-BIB0379|cit379","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1192\/pb.bp.108.021949","article-title":"Loss to outcomes stakeholder survey: the LOSS study","volume":"33","author":"Xia","year":"2009","journal-title":"Psychiatric Bulletin"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub5-BIB0380|cit380","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006569.pub4","article-title":"Aripiprazole versus other atypical antipsychotics for schizophrenia","author":"Khanna","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub5-BIB0381|cit381","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006569.pub3","article-title":"Aripiprazole versus other atypical antipsychotics for schizophrenia","author":"Komossa","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD006569.pub5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T18:38:55Z","timestamp":1690655935000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006569.pub5"}},"subtitle":[],"editor":[{"name":"Cochrane Schizophrenia Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,1,2]]},"references-count":381,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006569.pub5","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,2]]}}}